<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Mol Neurobiol</journal-id>
      <journal-title>Molecular Neurobiology</journal-title>
      <issn pub-type="ppub">0893-7648</issn>
      <issn pub-type="epub">1559-1182</issn>
      <publisher>
        <publisher-name>Humana Press Inc</publisher-name>
        <publisher-loc>New York</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">17952658</article-id>
      <article-id pub-id-type="pmc">2039784</article-id>
      <article-id pub-id-type="publisher-id">36</article-id>
      <article-id pub-id-type="doi">10.1007/s12035-007-0036-8</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Article</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Neuronal Chemokines: Versatile Messengers In Central Nervous System Cell Interaction</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>de Haas</surname>
            <given-names>A. H.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>van Weering</surname>
            <given-names>H. R. J.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>de Jong</surname>
            <given-names>E. K.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Boddeke</surname>
            <given-names>H. W. G. M.</given-names>
          </name>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes">
          <name name-style="western">
            <surname>Biber</surname>
            <given-names>K. P. H.</given-names>
          </name>
          <address>
            <email>k.p.h.biber@med.umcg.nl</email>
          </address>
          <xref ref-type="aff" rid="Aff1"/>
        </contrib>
        <aff id="Aff1">Department of Medical Physiology, University Medical Center Groningen, University of Groningen, Antonius Deusinglaan 1, Groningen, 9713 AV The Netherlands </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>10</day>
        <month>7</month>
        <year>2007</year>
      </pub-date>
      <pub-date pub-type="ppub">
        <month>10</month>
        <year>2007</year>
      </pub-date>
      <volume>36</volume>
      <issue>2</issue>
      <fpage>137</fpage>
      <lpage>151</lpage>
      <history>
        <date date-type="received">
          <day>13</day>
          <month>10</month>
          <year>2006</year>
        </date>
        <date date-type="accepted">
          <day>17</day>
          <month>1</month>
          <year>2007</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Humana Press Inc. 2007</copyright-statement>
      </permissions>
      <abstract>
        <p>Whereas chemokines are well known for their ability to induce cell migration, only recently it became evident that chemokines also control a variety of other cell functions and are versatile messengers in the interaction between a diversity of cell types. In the central nervous system (CNS), chemokines are generally found under both physiological and pathological conditions. Whereas many reports describe chemokine expression in astrocytes and microglia and their role in the migration of leukocytes into the CNS, only few studies describe chemokine expression in neurons. Nevertheless, the expression of neuronal chemokines and the corresponding chemokine receptors in CNS cells under physiological and pathological conditions indicates that neuronal chemokines contribute to CNS cell interaction. In this study, we review recent studies describing neuronal chemokine expression and discuss potential roles of neuronal chemokines in neuron&#x2013;astrocyte, neuron&#x2013;microglia, and neuron&#x2013;neuron interaction.</p>
      </abstract>
      <kwd-group>
        <title>Keywords</title>
        <kwd>CNS</kwd>
        <kwd>Central nervous system</kwd>
        <kwd>Neurons</kwd>
        <kwd>Astrocytes</kwd>
        <kwd>Microglia</kwd>
        <kwd>Chemokines</kwd>
        <kwd>Cell interaction</kwd>
      </kwd-group>
      <custom-meta-wrap>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; Humana Press 2007</meta-value>
        </custom-meta>
      </custom-meta-wrap>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1" sec-type="introduction">
      <title>Introduction</title>
      <p>Chemokines are small proteins that are able to induce a chemotactic response in cells expressing the corresponding chemokine receptors. Since the discovery of the first protein with chemotactic activity [<xref ref-type="bibr" rid="CR1">1</xref>], the chemokine family has expanded to approximately 50 chemokines [<xref ref-type="bibr" rid="CR2">2</xref>] and 20 receptors [<xref ref-type="bibr" rid="CR3">3</xref>]. Chemokines have been divided into four groups based on the position of four conserved cysteine residues in the N-terminal region of the protein. The two largest groups are CXC and CC. The first two cysteines in the CXC group are separated by one amino acid residue, whereas the first two cysteines in the CC group are adjacent to each other [<xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR5">5</xref>]. The two small groups are the C chemokines, with only one cysteine in the N-terminal region, and the CX3C chemokine, where the first two cysteines are separated by three amino acid residues [<xref ref-type="bibr" rid="CR5">5</xref>]. Chemokine receptors are designated according to the chemokine group they preferentially bind. For example, CC chemokines bind to CC receptors and so on. There has yet only been one exception reported, namely CCL21, that, in addition to CCR7, also binds to CXCR3 [<xref ref-type="bibr" rid="CR6">6</xref>&#x2013;<xref ref-type="bibr" rid="CR8">8</xref>]. All chemokine receptors belong to the family of G-protein coupled receptors (GPCRs). In general, GPCRs can bind many different G-proteins, allowing for a great variety of intracellular signaling pathways (for excellent review, see [<xref ref-type="bibr" rid="CR9">9</xref>]). The majority of chemokine-induced responses are inhibited by <italic>pertussis toxin</italic> (PTX), indicating that <inline-formula id="IEq1"><!-- Alternate image not processed: 12035_2007_36_Article_IEq1.gif --><tex-math id="M1">\documentclass[12pt]{minimal}
\usepackage{amsmath}
\usepackage{wasysym} 
\usepackage{amsfonts} 
\usepackage{amssymb} 
\usepackage{amsbsy}
\usepackage{mathrsfs}
\usepackage{upgreek}
\setlength{\oddsidemargin}{-69pt}
\begin{document}$$ {\text{G}}_{{{\text{ $  \alpha  $ i}}}} {\text{ - proteins}} $$\end{document}</tex-math></inline-formula> mediate many effects [<xref ref-type="bibr" rid="CR10">10</xref>]. Chemokine receptors can activate intracellular targets like adenylcyclase, phospholipases, GTPases like Rho, Rac, and Cdc42 and pathways of major kinases like mitogen-activated protein kinase (MAPK) and phosphatidyl inositol-3 kinase (PI3-K) [<xref ref-type="bibr" rid="CR11">11</xref>, <xref ref-type="bibr" rid="CR12">12</xref>]. This diversity of intracellular signaling shows that chemokine receptors, in addition to pathways involved in cell migration, also activate other pathways and may, in that way, control a great spectrum of cellular functions [<xref ref-type="bibr" rid="CR13">13</xref>, <xref ref-type="bibr" rid="CR14">14</xref>].</p>
      <p>Chemokines are well-known regulators of peripheral immune cell trafficking under both physiological and pathological conditions (reviewed by [<xref ref-type="bibr" rid="CR15">15</xref>&#x2013;<xref ref-type="bibr" rid="CR17">17</xref>]). In addition to chemo-attraction of immune cells, chemokines have been implicated in a variety of cell functions, such as early development, formation of secondary lymphoid organs, wound healing, angiogenesis and angiostasis, regulation of adhesion molecule expression, development of Th1/Th2 profiles, tumor growth, and metastasis [<xref ref-type="bibr" rid="CR5">5</xref>, <xref ref-type="bibr" rid="CR14">14</xref>, <xref ref-type="bibr" rid="CR18">18</xref>&#x2013;<xref ref-type="bibr" rid="CR24">24</xref>]. Thus, from being molecules thought to solely orchestrate immune cell migration, chemokines are now considered versatile messengers with the ability to control the interaction between a wide diversity of cell types.</p>
      <p>In addition to their presence in the periphery, numerous studies have demonstrated that chemokines are also expressed in the central nervous system (CNS), where they play a crucial role in physiological and pathological conditions, such as development, synaptic transmission, homeostasis, injury, and disease-associated neuroinflammation [<xref ref-type="bibr" rid="CR19">19</xref>, <xref ref-type="bibr" rid="CR25">25</xref>, <xref ref-type="bibr" rid="CR26">26</xref>]. Although astrocytes and microglia are the primary source of chemokines, there is evidence that neurons express and secrete chemokines as well, indicative of a neuronal contribution to chemokine signaling. In this paper, we review recent studies describing neuronal chemokine expression and discuss the potential roles of neuronal chemokines in neuron&#x2013;astrocyte, neuron&#x2013;microglia, and neuron&#x2013;neuron interaction.</p>
    </sec>
    <sec id="Sec2">
      <title>Neuronal Chemokine Expression</title>
      <p>Approximately 60 studies describe chemokine expression in neurons under physiological and pathological conditions (see Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>). These studies, of which the majority is published in the last 3&#xA0;years, are reviewed in the following sections.
<table-wrap id="Tab1"><label>Table&#xA0;1</label><caption><p>Neuronal chemokine expression</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chemokine</th><th>Species</th><th>Condition</th><th>RNA</th><th>Protein</th><th>References</th></tr></thead><tbody><tr><td rowspan="13">CCL2</td><td>h</td><td>Brain</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR39">39</xref>]</td></tr><tr><td/><td>Spinal cord, ALS</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR35">35</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td/><td>Cell line</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td>r</td><td>Brain</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR37">37</xref>]</td></tr><tr><td/><td>Brain, cranial nerve injury</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR30">30</xref>]</td></tr><tr><td/><td>Brain, ischemia</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR28">28</xref>]</td></tr><tr><td/><td>Retina, ischemia</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR168">168</xref>]</td></tr><tr><td/><td>Spinal cord, peripheral nerve injury</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR31">31</xref>&#x2013;<xref ref-type="bibr" rid="CR34">34</xref>]</td></tr><tr><td/><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR164">164</xref>]</td></tr><tr><td>m</td><td>Brain, ischemia</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR27">27</xref>, <xref ref-type="bibr" rid="CR29">29</xref>]</td></tr><tr><td/><td>Spinal cord, ALS model</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR36">36</xref>]</td></tr><tr><td/><td>Monoculture, West Nile virus</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td rowspan="5">CCL3</td><td>h</td><td>Brain, AD</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR40">40</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>r</td><td>Retina, ischemia</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR168">168</xref>]</td></tr><tr><td/><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td rowspan="3">CCL4</td><td>h</td><td>Monoculture</td><td>&#x2191;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>r</td><td>Retina, ischemia</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR168">168</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR42">42</xref>]</td></tr><tr><td rowspan="2">CCL5</td><td>h</td><td>Monoculture</td><td>&#x2191;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>]</td></tr><tr><td rowspan="2">CCL20</td><td>r</td><td>Monoculture</td><td/><td>+/&#x2191;</td><td>[<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td/><td>Trigeminal neuron culture</td><td>&#x2193;</td><td/><td>[<xref ref-type="bibr" rid="CR169">169</xref>]</td></tr><tr><td rowspan="3">CCL21</td><td>m</td><td>Brain, ischemia</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR45">45</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td/><td>Neonatal hippocampal slice culture</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR46">46</xref>]</td></tr><tr><td>CXCL1/2/3</td><td>r</td><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR51">51</xref>]</td></tr><tr><td>CXCL8</td><td>h</td><td>Monoculture</td><td>+</td><td/><td>[<xref ref-type="bibr" rid="CR41">41</xref>]</td></tr><tr><td>CXCL9</td><td>m</td><td>Monoculture</td><td>+</td><td/><td>[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td rowspan="7">CXCL10</td><td>h</td><td>Brain, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td/><td>Mixed brain culture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td>mac</td><td>Brain, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td>r</td><td>Brain, ischemia</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR52">52</xref>]</td></tr><tr><td>m</td><td>Brain, entorhinal cortex lesion</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR53">53</xref>]</td></tr><tr><td/><td>Brain, West Nile virus</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td>CXCL11</td><td>m</td><td>Monoculture</td><td>+</td><td/><td>[<xref ref-type="bibr" rid="CR43">43</xref>]</td></tr><tr><td rowspan="7">CXCL12</td><td>h</td><td>Brain, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td/><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td>r</td><td>Brain</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR55">55</xref>, <xref ref-type="bibr" rid="CR60">60</xref>&#x2013;<xref ref-type="bibr" rid="CR62">62</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR60">60</xref>, <xref ref-type="bibr" rid="CR87">87</xref>]</td></tr><tr><td>m</td><td>Brain, ischemia</td><td>&#x2248;/&#x2193;</td><td/><td>[<xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td/><td>Brain, LPS injection</td><td>&#x2248;</td><td/><td>[<xref ref-type="bibr" rid="CR56">56</xref>]</td></tr><tr><td/><td>Mixed brain culture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR59">59</xref>]</td></tr><tr><td rowspan="18">CX3CL1</td><td>h</td><td>Brain, MS</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td/><td>Brain, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR170">170</xref>]</td></tr><tr><td/><td>Spinal cord</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2248;</td><td>&#x2248;/&#x2191;/&#x2193;</td><td>[<xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR138">138</xref>]</td></tr><tr><td/><td>Cell line</td><td>&#x2248;</td><td>&#x2191;/&#x2193;<sup>a</sup></td><td>[<xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR138">138</xref>]</td></tr><tr><td>mac</td><td>Brain</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td>r</td><td>Brain and spinal cord, EAE</td><td>&#x2248;</td><td/><td>[<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR68">68</xref>]</td></tr><tr><td/><td>Spinal cord, peripheral nerve injury</td><td>&#x2248;</td><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR171">171</xref>, <xref ref-type="bibr" rid="CR172">172</xref>]</td></tr><tr><td/><td>Brain, LPS injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Brain, KA injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2248;</td><td>&#x2191;/&#x2193;<sup>a</sup></td><td>[<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR118">118</xref>]</td></tr><tr><td>m</td><td>Brain</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR69">69</xref>]</td></tr><tr><td/><td>Brain, prion disease</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Brain, LPS injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Brain, KA injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Brain, EAE</td><td>&#x2248;</td><td/><td>[<xref ref-type="bibr" rid="CR66">66</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2248;</td><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR77">77</xref>]</td></tr><tr><td/><td>Cell line</td><td>&#x2248;</td><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR77">77</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>h</italic> Human, <italic>mac</italic> macaque, <italic>r</italic> rat, <italic>m</italic> mouse, <italic>ALS</italic> amyotrophic lateral sclerosis, <italic>AD</italic> Alzheimer&#x2019;s disease, <italic>HIV</italic> human immunodeficiency virus, <italic>MS</italic> multiple sclerosis, <italic>EAE</italic> experimental autoimmune encephalomyelitis, <italic>LPS</italic> lipopolysaccharide, <italic>KA</italic> kanaic acid; <italic>+</italic> present, <italic>&#x2248;</italic> present without change in mentioned conditions, <italic>&#x2191;</italic> present with increase in mentioned conditions, <italic>&#x2193;</italic> present with decrease in mentioned conditions,</p><p><sup>a</sup>Increase in soluble CX3CL1 and decrease in membrane-bound CX3CL1</p></table-wrap-foot></table-wrap></p>
      <sec id="Sec3">
        <title>CC Chemokines</title>
        <sec id="Sec4">
          <title>CCL2</title>
          <p>CCL2 is currently the most extensively described neuronal chemokine. The majority of reports describing neuronal CCL2 expression are focused on pathological conditions. An induction of neuronal CCL2 expression was described upon ischemia [<xref ref-type="bibr" rid="CR27">27</xref>&#x2013;<xref ref-type="bibr" rid="CR29">29</xref>], after axonal injury [<xref ref-type="bibr" rid="CR30">30</xref>&#x2013;<xref ref-type="bibr" rid="CR34">34</xref>] and in motoneurons of patients with amyotrophic lateral sclerosis (ALS), and in mouse models for ALS [<xref ref-type="bibr" rid="CR35">35</xref>, <xref ref-type="bibr" rid="CR36">36</xref>]. Interestingly, neuronal CCL2 expression in response to ischemia was detectable within 2&#xA0;h, whereas CCL2 expression in astrocytes was detected only after 2&#xA0;days [<xref ref-type="bibr" rid="CR27">27</xref>]. Although most reports show induction of neuronal CCL2 expression under pathological conditions, a recent study has shown constitutive CCL2 expression in neurons throughout the rat brain [<xref ref-type="bibr" rid="CR37">37</xref>]. This study demonstrated that, depending on the brain region, up to 100% of the neurons were positive for CCL2 [<xref ref-type="bibr" rid="CR37">37</xref>]. CCL2 was mainly detected in neuronal cell bodies and costaining-depicted colocalization with various neurotransmitters and neuropeptides, corroborating a population-specific expression of CCL2 [<xref ref-type="bibr" rid="CR37">37</xref>]. Constitutive neuronal CCL2 expression was also shown in a human neuronal cell line [<xref ref-type="bibr" rid="CR38">38</xref>] and during human CNS development [<xref ref-type="bibr" rid="CR39">39</xref>].</p>
        </sec>
        <sec id="Sec5">
          <title>CCL3, CCL4, and CCL5</title>
          <p>At present, there is only one study describing neuronal CCL3 expression in situ, depicting protein expression in adult human brain [<xref ref-type="bibr" rid="CR40">40</xref>]. Further, expression of CCL3, CCL4, and CCL5 was described in cultured forebrain neurons derived from human first trimester embryos. These chemokines showed increased expression after exposure to immunological stimuli [<xref ref-type="bibr" rid="CR41">41</xref>]. CCL3 and CCL4 expression were induced in mouse cerebellar granule neurons after infection with <italic>Toxoplasma gondii</italic> [<xref ref-type="bibr" rid="CR42">42</xref>], as was CCL5 expression after viral infections [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR44">44</xref>].</p>
        </sec>
        <sec id="Sec6">
          <title>CCL21</title>
          <p>In a middle cerebral artery occlusion (MCAO) mouse model of brain ischemia, cortical neurons rapidly expressed CCL21 in the penumbra of the ischemic core. Because control brain tissue did not express CCL21, CCL21 was assumed to be specifically expressed in endangered neurons [<xref ref-type="bibr" rid="CR45">45</xref>]. In accordance with the in vivo findings, CCL21 expression was induced in cortical neurons in vitro within 2&#xA0;h after excitotoxicity [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>]. The CCL21 expression in endangered neurons was rather surprising, as CCL21 is well known for its constitutive expression in secondary lymphoid organs, controlling the homing of mature dendritic cells and na&#xEF;ve T cells [<xref ref-type="bibr" rid="CR47">47</xref>] and is, therefore, generally considered a homeostatic chemokine linked to the development and maintenance of secondary lymphoid organs [<xref ref-type="bibr" rid="CR48">48</xref>]. The rapid CCL21 expression in endangered neurons after injury indicates a brain specific role of CCL21. This assumption is corroborated by findings in transgenic mice in which CCL21 was expressed ectopically in various tissues. CCL21 expression in the brain induced a massive brain inflammation that killed the animals within 3&#xA0;days after the expression onset [<xref ref-type="bibr" rid="CR49">49</xref>], whereas CCL21 expression in the skin induced the formation of secondary lymphoid structures [<xref ref-type="bibr" rid="CR50">50</xref>].</p>
        </sec>
        <sec id="Sec7">
          <title>Other CC Chemokines</title>
          <p>A single study has demonstrated a constitutive and inducible expression of CCL20 in rat cerebellar granule neurons in vitro, which was suggested to play a role in neuronal apoptosis [<xref ref-type="bibr" rid="CR51">51</xref>]. Expression of other CC chemokines has not yet been observed in neurons.</p>
        </sec>
      </sec>
      <sec id="Sec8">
        <title>CXC Chemokines</title>
        <sec id="Sec9">
          <title>CXCL10</title>
          <p>CXCL10 expression was first described in cortical neurons in rat in response to MCAO-induced brain ischemia [<xref ref-type="bibr" rid="CR52">52</xref>]. Remarkably, neuronal CXCL10 expression was transient and appeared rapidly after stroke (within 3&#x2013;12&#xA0;h), whereas CXCL10 expression in astrocytes was detectable later and persisted up to 15&#xA0;days after MCAO [<xref ref-type="bibr" rid="CR52">52</xref>]. Correspondingly, neurons also showed a rapid CXCL10 expression after entorhinal cortex lesion [<xref ref-type="bibr" rid="CR53">53</xref>]. Further, neuronal CXCL10 expression and release was induced after viral infection in vitro and in vivo [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR54">54</xref>].</p>
        </sec>
        <sec id="Sec10">
          <title>CXCL12</title>
          <p>The CXCL12 gene contains three splice variants, termed stromal cell-derived factor-1 (SDF-1) &#x3B1;, &#x3B2;, and &#x3B3;. SDF-1&#x3B3; was cloned from rat brain and showed constitutive neuronal mRNA expression with almost no change in level after peripheral nerve injury [<xref ref-type="bibr" rid="CR55">55</xref>]. In addition, SDF-1&#x3B1; showed neuronal mRNA expression with almost no change in level after brain ischemia or intracerebral LPS injection [<xref ref-type="bibr" rid="CR56">56</xref>]. In contrast, SDF-1 &#x3B2; mRNA expression was not detected in neurons [<xref ref-type="bibr" rid="CR56">56</xref>]. As little is known about the role of SDF splice variants, and most studies did not specify the splice variants, CXCL12 is used for all SDF splice variants henceforth.</p>
          <p>Like CCL2, but in contrast to most of the other neuronal chemokines, CXCL12 is expressed constitutively in specific neuronal populations. Neuronal CXCL12 expression in vitro was observed in cultured cortical, hippocampal, and cerebellar neurons from human, rat, and mouse [<xref ref-type="bibr" rid="CR57">57</xref>&#x2013;<xref ref-type="bibr" rid="CR60">60</xref>]. Neuronal CXCL12 expression in vivo was studied in detail in the adult rat brain, showing CXCL12 mRNA and protein expression in cholinergic, dopaminergic, and vasopressin containing neurons throughout the brain [<xref ref-type="bibr" rid="CR61">61</xref>, <xref ref-type="bibr" rid="CR62">62</xref>].</p>
        </sec>
        <sec id="Sec11">
          <title>Other CXC Chemokines</title>
          <p>Studies describing the expression of other CXC chemokines in neurons are limited. Most notably, in vitro neuronal mRNA expression of CXCL1 [<xref ref-type="bibr" rid="CR51">51</xref>], CXCL8 [<xref ref-type="bibr" rid="CR41">41</xref>], CXCL9, and CXCL11 [<xref ref-type="bibr" rid="CR43">43</xref>] has been illustrated. Expression of other CXC chemokines has not yet been described in neurons.</p>
        </sec>
        <sec id="Sec12">
          <title>CX3CL1</title>
          <p>CX3CL1 was the first chemokine shown to be expressed in neurons [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR66">66</xref>]. Because microglia were shown to express the corresponding receptor CX3CR1, a role of CX3CL1&#x2013;CX3CR1 signaling in neuron&#x2013;microglia interaction was suggested [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR65">65</xref>]. CX3CL1 is constitutively expressed in human, macaque, rat, and mouse neurons in vitro and in vivo, with high expression in cerebral cortex, hippocampus, caudate putamen, thalamus, and olfactory bulb [<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR66">66</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR69">69</xref>]. CX3CL1 appears to be the only chemokine with a higher expression level in brain than in peripheral organs [<xref ref-type="bibr" rid="CR70">70</xref>]. It is membrane bound and can be cleaved from the cell surface by proteases of the A Disintegrin and Metalloprotease (ADAM) family [<xref ref-type="bibr" rid="CR71">71</xref>, <xref ref-type="bibr" rid="CR72">72</xref>]. The neuronal CX3CL1 mRNA expression remained relatively stable in response to both neuron-damaging stimuli in vitro [<xref ref-type="bibr" rid="CR73">73</xref>&#x2013;<xref ref-type="bibr" rid="CR77">77</xref>] and during neuroinflammation in vivo [<xref ref-type="bibr" rid="CR66">66</xref>], whereas in vitro neurons released CX3CL1 protein after glutamate-induced damage [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Furthermore, CX3CL1 concentrations higher than 300&#xA0;pg/mg were described in aqueous extracts of the brain [<xref ref-type="bibr" rid="CR79">79</xref>], indicating that CX3CL1 can be cleaved from the neuronal membrane and released into the extracellular environment. It is yet unknown which ADAM protease cleaves CX3CL1 in neurons and whether CX3CL1 protein expression changes during in vivo neuroinflammation or degeneration.</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec13">
      <title>Potential Roles of Neuronal Chemokines in Neuron&#x2013;Astrocyte, Neuron&#x2013;Microglia, and Neuron&#x2013;Neuron Interaction</title>
      <p>Astrocytes, microglia, and neurons have been shown to express chemokine receptors in vitro under physiological and pathological conditions and in vivo. These would include CCR2 for CCL2, CXCR3 for CCL21 and CXCL10, CXCR4 for CXCL12, and CX3CR1 for CX3CL1. Studies describing the expression of these chemokine receptors on astrocytes, microglia, and neurons (see Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>) and studies indicating a role for these chemokine&#x2013;chemokine receptor pairs in CNS cell interaction are discussed in the following sections on neuron&#x2013;astrocyte, neuron&#x2013;microglia, and neuron&#x2013;neuron interaction.
<table-wrap id="Tab2"><label>Table&#xA0;2</label><caption><p>Chemokine receptor expression in astrocytes, microglia, and neurons</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Chemokine</th><th>Receptor</th><th>Cell type</th><th>Species</th><th>Condition</th><th>RNA</th><th>Protein</th><th>References</th></tr></thead><tbody><tr><td rowspan="15">CCL2</td><td rowspan="15">CCR2</td><td rowspan="4">astrocyte</td><td>h</td><td>Brain, MS, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR173">173</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR174">174</xref>&#x2013;<xref ref-type="bibr" rid="CR176">176</xref>]</td></tr><tr><td>mac</td><td>Monoculture</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR175">175</xref>]</td></tr><tr><td>r</td><td>Brain, EAE, LPS injection</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR177">177</xref>, <xref ref-type="bibr" rid="CR178">178</xref>]</td></tr><tr><td rowspan="6">microglia</td><td>h</td><td>Brain, MS, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR96">96</xref>, <xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR179">179</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2193;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR180">180</xref>]</td></tr><tr><td/><td>Glia culture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR99">99</xref>]</td></tr><tr><td>r</td><td>Brain, tumor, LPS injection, NMDA injection</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR177">177</xref>, <xref ref-type="bibr" rid="CR181">181</xref>, <xref ref-type="bibr" rid="CR182">182</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR88">88</xref>]</td></tr><tr><td>m</td><td>Spinal cord, peripheral nerve injury</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR183">183</xref>]</td></tr><tr><td rowspan="5">neuron</td><td>h</td><td>Brain, HIV</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR184">184</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td/><td>Cell line</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td>r</td><td>Brain and spinal cord</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR177">177</xref>, <xref ref-type="bibr" rid="CR185">185</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR161">161</xref>, <xref ref-type="bibr" rid="CR164">164</xref>]</td></tr><tr><td rowspan="16">CXCL10/CCL21</td><td rowspan="16">CXCR3</td><td rowspan="5">astrocyte</td><td>h</td><td>Brain, MS, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR97">97</xref>, <xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR186">186</xref>]</td></tr><tr><td/><td>Astrocyte culture</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR175">175</xref>]</td></tr><tr><td/><td>Mixed glial culture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR95">95</xref>]</td></tr><tr><td>mac</td><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR175">175</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td rowspan="6">microglia</td><td>h</td><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR114">114</xref>]</td></tr><tr><td/><td>Cell line</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR98">98</xref>]</td></tr><tr><td>r</td><td>Cell line</td><td>&#x2191;/&#x2193;</td><td/><td>[<xref ref-type="bibr" rid="CR187">187</xref>]</td></tr><tr><td>m</td><td>Brain, various infectious agents, axotomy</td><td>&#x2248;/&#x2191;</td><td>&#x2248;/&#x2191;</td><td>[<xref ref-type="bibr" rid="CR125">125</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>&#x2193;</td><td>[<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR84">84</xref>]</td></tr><tr><td/><td>Cell line</td><td>&#x2191;/&#x2193;</td><td/><td>[<xref ref-type="bibr" rid="CR188">188</xref>]</td></tr><tr><td rowspan="5">neuron</td><td>h</td><td>Brain, AD</td><td>+</td><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR95">95</xref>, <xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR189">189</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td/><td>Cell line</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>]</td></tr><tr><td>mac</td><td>Brain, HIV</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR54">54</xref>]</td></tr><tr><td>r</td><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR163">163</xref>]</td></tr><tr><td rowspan="21">CXCL12</td><td rowspan="21">CXCR4</td><td rowspan="6">astrocyte</td><td>h</td><td>Brain, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR191">191</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR90">90</xref>, <xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR175">175</xref>, <xref ref-type="bibr" rid="CR192">192</xref>&#x2013;<xref ref-type="bibr" rid="CR196">196</xref>]</td></tr><tr><td>mac</td><td>Monoculture</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR175">175</xref>]</td></tr><tr><td>r</td><td>Brain</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR197">197</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;/&#x2193;</td><td>&#x2191;/&#x2193;</td><td>[<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR198">198</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td>&#x2191;/&#x2193;</td><td>&#x2191;/&#x2193;</td><td>[<xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR101">101</xref>, <xref ref-type="bibr" rid="CR104">104</xref>, <xref ref-type="bibr" rid="CR199">199</xref>, <xref ref-type="bibr" rid="CR200">200</xref>]</td></tr><tr><td rowspan="7">microglia</td><td>h</td><td>Brain and spinal cord, HIV</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR173">173</xref>, <xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR190">190</xref>, <xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR201">201</xref>, <xref ref-type="bibr" rid="CR202">202</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>&#x2193;</td><td>[<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>, <xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR202">202</xref>&#x2013;<xref ref-type="bibr" rid="CR205">205</xref>]</td></tr><tr><td/><td>Cell line</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR98">98</xref>]</td></tr><tr><td>bab</td><td>Monoculture</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR206">206</xref>]</td></tr><tr><td>r</td><td>Brain</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR197">197</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2248;/&#x2191;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR58">58</xref>, <xref ref-type="bibr" rid="CR207">207</xref>, <xref ref-type="bibr" rid="CR198">198</xref>]</td></tr><tr><td>m</td><td>Cell line</td><td>+</td><td/><td>[<xref ref-type="bibr" rid="CR86">86</xref>]</td></tr><tr><td rowspan="8">neuron</td><td>h</td><td>Brain, HIV</td><td>+</td><td>&#x2248;/&#x2191;</td><td>[<xref ref-type="bibr" rid="CR179">179</xref>, <xref ref-type="bibr" rid="CR184">184</xref>, <xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR197">197</xref>, <xref ref-type="bibr" rid="CR202">202</xref>, <xref ref-type="bibr" rid="CR204">204</xref>, <xref ref-type="bibr" rid="CR208">208</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td/><td>Mixed brain culture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR202">202</xref>]</td></tr><tr><td/><td>Cell line</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR38">38</xref>, <xref ref-type="bibr" rid="CR191">191</xref>, <xref ref-type="bibr" rid="CR209">209</xref>]</td></tr><tr><td>mac</td><td>Brain</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR210">210</xref>, <xref ref-type="bibr" rid="CR211">211</xref>]</td></tr><tr><td/><td>Monoculture</td><td/><td>+</td><td>[<xref ref-type="bibr" rid="CR85">85</xref>]</td></tr><tr><td>r</td><td>Brain</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR57">57</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR158">158</xref>]</td></tr><tr><td rowspan="21">CX3CL1</td><td rowspan="21">CX3CR1</td><td rowspan="5">astrocyte</td><td>h</td><td>Brain, MS</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;</td><td>+</td><td>[<xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR175">175</xref>]</td></tr><tr><td>mac</td><td>Monoculture</td><td>&#x2191;</td><td/><td>[<xref ref-type="bibr" rid="CR175">175</xref>]</td></tr><tr><td>r</td><td>Monoculture</td><td>&#x2248;/&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR198">198</xref>, <xref ref-type="bibr" rid="CR212">212</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td>&#x2193;</td><td>&#x2193;</td><td>[<xref ref-type="bibr" rid="CR77">77</xref>, <xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR200">200</xref>]</td></tr><tr><td rowspan="10">microglia</td><td>h</td><td>Brain, MS</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td/><td>Brain, HIV</td><td/><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR170">170</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR75">75</xref>, <xref ref-type="bibr" rid="CR113">113</xref>]</td></tr><tr><td>r</td><td>Brain, ischemia, prion disease, cranial nerve injury, EAE</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR67">67</xref>, <xref ref-type="bibr" rid="CR68">68</xref>, <xref ref-type="bibr" rid="CR213">213</xref>]</td></tr><tr><td/><td>Brain, LPS injection, KA injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Spinal cord, peripheral nerve injury</td><td>&#x2191;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR171">171</xref>, <xref ref-type="bibr" rid="CR172">172</xref>]</td></tr><tr><td/><td>Monoculture</td><td>&#x2191;/&#x2193;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR63">63</xref>, <xref ref-type="bibr" rid="CR65">65</xref>, <xref ref-type="bibr" rid="CR198">198</xref>, <xref ref-type="bibr" rid="CR212">212</xref>, <xref ref-type="bibr" rid="CR214">214</xref>]</td></tr><tr><td/><td>Cell line</td><td>&#x2193;</td><td/><td>[<xref ref-type="bibr" rid="CR187">187</xref>]</td></tr><tr><td/><td>Brain, LPS injection, KA injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td>m</td><td>Monoculture</td><td>&#x2248;</td><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR77">77</xref>]</td></tr><tr><td rowspan="6">neuron</td><td>h</td><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR75">75</xref>]</td></tr><tr><td/><td>Cell line</td><td>&#x2248;</td><td>&#x2191;</td><td>[<xref ref-type="bibr" rid="CR75">75</xref>]</td></tr><tr><td>r</td><td>Brain, LPS injection, KA injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Monoculture</td><td>+</td><td>+</td><td>[<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR139">139</xref>]</td></tr><tr><td>m</td><td>Brain, prion disease</td><td/><td>&#x2193;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr><tr><td/><td>Brain, LPS injection, KA injection</td><td/><td>&#x2248;</td><td>[<xref ref-type="bibr" rid="CR67">67</xref>]</td></tr></tbody></table><table-wrap-foot><p><italic>h</italic> human, <italic>mac</italic> macaque, <italic>bab</italic> baboon, <italic>r</italic> rat, <italic>m</italic> mouse, <italic>MS</italic> multiple sclerosis, <italic>HIV</italic> human immunodeficiency virus, <italic>EAE</italic> experimental autoimmune encephalomyelitis, <italic>LPS</italic> lipopolysaccharide, <italic>NMDA</italic><italic>N</italic>-methyl-<sc>d</sc>-aspartatic acid, <italic>AD</italic> Alzheimer&#x2019;s disease, <italic>KA</italic> kainic acid; <italic>+</italic> present, <italic>&#x2248;</italic> present without change in mentioned conditions, <italic>&#x2191;</italic> present with increase in mentioned conditions, <italic>&#x2193;</italic> present with decrease in mentioned conditions</p></table-wrap-foot></table-wrap></p>
      <sec id="Sec14">
        <title>Neuron&#x2013;Astrocyte Interaction</title>
        <p>Astrocytes comprise the largest group of CNS-residing cells and are not only essential in development, homeostasis, maintenance of the blood&#x2013;brain barrier, and regulation of central blood flow but are also involved in the immune defense of the CNS. Furthermore, astrocytes are considered to be involved in neuronal information processing [<xref ref-type="bibr" rid="CR80">80</xref>].</p>
        <p>It is becoming clear that astrocytes play an active role in the intricate chemokine network of the CNS. Not only has it been shown that astrocytes express a wide variety of constitutive and inducible chemokines in vivo and in vitro, there is also extensive evidence that they express a repertoire of chemokine receptors under physiological and pathological conditions (see reviews [<xref ref-type="bibr" rid="CR81">81</xref>, <xref ref-type="bibr" rid="CR82">82</xref>]).</p>
        <sec id="Sec15">
          <title>Neuronal Chemokines Induce Calcium Transients in Astrocytes</title>
          <p>The activation of intracellular calcium transients is a hallmark in chemokine receptor signaling, a mechanism that also holds true for astrocytes [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR83">83</xref>&#x2013;<xref ref-type="bibr" rid="CR86">86</xref>]. Activation of GPCRs, including chemokine receptors, results in a rapid release of calcium from the endoplasmatic reticulum (ER) through the activation of inositol-1,4,5-triphosphate receptors on the ER membrane. One of the first chemokines described to induce calcium transients in astrocytes is CXCL12 [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR85">85</xref>&#x2013;<xref ref-type="bibr" rid="CR87">87</xref>]. CXCL12 concentrations ranging from 0.1 to 100&#xA0;ng/ml [<xref ref-type="bibr" rid="CR85">85</xref>, <xref ref-type="bibr" rid="CR86">86</xref>] or 10&#x2013;100&#xA0;nM [<xref ref-type="bibr" rid="CR57">57</xref>, <xref ref-type="bibr" rid="CR87">87</xref>] induced calcium fluxes in in vitro human, rat, and mouse astrocytes. In all cases, CXCL12-induced calcium mobilization was PTX-sensitive, indicating that this process is G&#x3B1;<sub>i</sub>-protein mediated. Similar results were found for CXCL10 [<xref ref-type="bibr" rid="CR84">84</xref>], CCL2 [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR88">88</xref>], and CX3CL1 [<xref ref-type="bibr" rid="CR76">76</xref>].</p>
          <p>In astrocytes, intracellular calcium transients not only function as a second messenger in multiple intracellular signaling pathways but are also implicated in astrocyte&#x2013;astrocyte signal propagation, astrocyte&#x2013;neuron synaptic transmission, and neurotransmitter release (see reviews [<xref ref-type="bibr" rid="CR80">80</xref>, <xref ref-type="bibr" rid="CR89">89</xref>]). Recent findings corroborate that chemokines could also be involved in astrocyte-mediated neurotransmitter release. CXCL12 induced calcium-dependent release of glutamate from astrocytes in human and rat astrocyte cultures and rat hippocampal slice cultures [<xref ref-type="bibr" rid="CR90">90</xref>]. Moreover, reports that investigated the effects of CXCL12 on the electrophysiological properties of neurons in brain slice cultures suggest that CXCL12-induced effects on neurons at least partly depend on astrocytic glutamate release [<xref ref-type="bibr" rid="CR91">91</xref>&#x2013;<xref ref-type="bibr" rid="CR93">93</xref>]. Whether this astrocytic glutamate release was induced by CXCR4 activation or via other pathways was not investigated.</p>
        </sec>
        <sec id="Sec16">
          <title>Neuronal Chemokines Induce Astrocyte Proliferation and Migration in Vitro: Implications for Astrogliosis?</title>
          <p>Astrocytes respond to CNS injury or neuroinflammation by enhanced GFAP expression, proliferation, and possibly, migration, a process known as astrogliosis (see review [<xref ref-type="bibr" rid="CR94">94</xref>]). In these reactive astrocytes, enhanced expression of chemokine receptors has been described under various pathological conditions, such as multiple sclerosis (MS), human immunodeficiency virus (HIV) infection, ischemia, and neoplasm [<xref ref-type="bibr" rid="CR95">95</xref>&#x2013;<xref ref-type="bibr" rid="CR97">97</xref>]. Under these conditions, CXCR3 was mainly found in reactive astrocytes in the proximity of the lesion sites, suggesting that induction of CXCR3 expression in astrocytes is limited to damaged areas of the brain [<xref ref-type="bibr" rid="CR95">95</xref>&#x2013;<xref ref-type="bibr" rid="CR97">97</xref>]. A comparable induction of CCR2 expression was found in reactive astrocytes in MS patients [<xref ref-type="bibr" rid="CR97">97</xref>].</p>
          <p>Interestingly, both CCL2 and CXCL10 are implicated in astrocyte proliferation in vitro [<xref ref-type="bibr" rid="CR98">98</xref>, <xref ref-type="bibr" rid="CR99">99</xref>]. In addition, CXCL12 has been shown to induce astrocyte proliferation in vitro, a process that is dependent on activation of extracellular signal-regulated kinases ERK1 and ERK2 [<xref ref-type="bibr" rid="CR87">87</xref>, <xref ref-type="bibr" rid="CR100">100</xref>&#x2013;<xref ref-type="bibr" rid="CR102">102</xref>]. Both CXCL12-induced astrocyte proliferation and ERK1/2 activation was inhibited by PTX and wortmannin, suggesting that they are dependent on upstream activation of G&#x3B1;<sub>i</sub> proteins and PI3-K [<xref ref-type="bibr" rid="CR87">87</xref>].</p>
          <p>As chemokines are primarily known for their capacity to induce cell migration, migration assays have been used to determine chemokine receptor functionality in astrocytes [<xref ref-type="bibr" rid="CR103">103</xref>]. Accordingly, astrocyte migration was demonstrated in vitro in response to CCL2, CXCL10, and CXCL12 [<xref ref-type="bibr" rid="CR83">83</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR86">86</xref>, <xref ref-type="bibr" rid="CR103">103</xref>, <xref ref-type="bibr" rid="CR104">104</xref>]. Thus, reactive astrocytes express various chemokine receptors and activation of these receptors in vitro induces proliferation and migration, cellular reactions that are generally involved in astrogliosis. Therefore, it is tempting to speculate that chemokines are involved in the regulation of astrogliosis upon CNS injury or neuroinflammation. Whether neuronal chemokines are indeed responsible for either proliferation or migration of astrocytes in vivo is yet unknown.</p>
        </sec>
      </sec>
      <sec id="Sec17">
        <title>Neuron&#x2013;Microglia Interaction</title>
        <p>Microglia in the healthy CNS are ramified cells that continually survey their environment by moving their processes. Upon injury, they quickly protrude their processes toward the damaged site and subsequently transform into amoeboid cells, reflecting a fast activation [<xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>]. Activated microglia form a first line of defense in CNS injury through their capacity to migrate, proliferate, secrete inflammatory and neurotrophic factors, phagocytose-damaged cells and debris, and present antigens [<xref ref-type="bibr" rid="CR82">82</xref>, <xref ref-type="bibr" rid="CR107">107</xref>]. Although activated microglia were initially considered to be detrimental in CNS injury, recent findings indicate a prominent neuroprotective activity as well, suggesting a balance between neurotoxic and neuroprotective microglia activity (see for recent review, [<xref ref-type="bibr" rid="CR108">108</xref>]). Therefore, it is of particular interest to gain insight into the process of microglia activation. Until now, it is largely unknown which environmental signals mediate microglia surveillance and activation. Almost 10&#xA0;years ago, chemokines were indicated as promising candidates for neuron&#x2013;microglia signaling [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR65">65</xref>]. Because then, various studies have described constitutive chemokine expression in neurons and rapid changes in expression levels upon injury. Parallel to this, corresponding chemokine receptors were described in resting and/or activated microglia. In addition, there is increasing evidence that neurons play an important role in microglia activity, which is at least partly mediated by chemokines.</p>
        <sec id="Sec18">
          <title>Microglia Activity Upon Neuronal Damage</title>
          <p>Upon CNS injury, activated microglia retract their protrusions, transforming into amoeboid cells with migratory and/or proliferative capacities [<xref ref-type="bibr" rid="CR109">109</xref>&#x2013;<xref ref-type="bibr" rid="CR111">111</xref>]. It is known that damaged neurons are accompanied by prominent activated microglia within hours after injury, suggesting that neurons emit signals that attract microglia [<xref ref-type="bibr" rid="CR111">111</xref>]. Several findings support the notion that these signals are primarily chemokines. Microglia express various chemokine receptors, and cell migration is induced upon exposure to chemokines in vitro [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR112">112</xref>&#x2013;<xref ref-type="bibr" rid="CR115">115</xref>]. Moreover, damaged neurons in culture express and release chemokines like CX3CL1 [<xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR74">74</xref>, <xref ref-type="bibr" rid="CR78">78</xref>], CCL21 [<xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>], and CXCL10 [<xref ref-type="bibr" rid="CR43">43</xref>, <xref ref-type="bibr" rid="CR54">54</xref>], all of which are able to induce microglia migration [<xref ref-type="bibr" rid="CR7">7</xref>, <xref ref-type="bibr" rid="CR45">45</xref>, <xref ref-type="bibr" rid="CR46">46</xref>, <xref ref-type="bibr" rid="CR73">73</xref>, <xref ref-type="bibr" rid="CR76">76</xref>, <xref ref-type="bibr" rid="CR84">84</xref>, <xref ref-type="bibr" rid="CR113">113</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. In accordance with this, inhibition of chemokine function diminished microglia migration in response to supernatants from damaged neurons [<xref ref-type="bibr" rid="CR73">73</xref>]. Thus, in vitro results suggest a role of neuronal chemokines in neuron&#x2013;microglia activation.</p>
          <p>The issue of chemokine-mediated neuron&#x2013;microglia activation has been further investigated using genetically modified mice. Mice deficient for either CX3CR1 [<xref ref-type="bibr" rid="CR116">116</xref>] and CX3CL1 [<xref ref-type="bibr" rid="CR117">117</xref>] have been studied in various CNS injury and neuroinflammation models. Although CX3CR1 deficiency did not influence microglia activity in response to facial nerve lesion [<xref ref-type="bibr" rid="CR116">116</xref>], CX3CR1 deficiency was uniformly associated with higher levels of microglia activity in LPS-induced neuroinflammation, 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridin-induced neurotoxicity, and in the SOD1<sup>G93A</sup>-model of motoneuronal death in the spinal cord [<xref ref-type="bibr" rid="CR79">79</xref>]. Interestingly, enhanced microglia activity in the last three models was accompanied by increased neuronal death, indicating that, in wild-type mice, neurotoxic microglia activity is inhibited by CX3CL1&#x2013;CX3CR1 signaling [<xref ref-type="bibr" rid="CR79">79</xref>]. These findings are corroborated by several in vitro findings. Exposure of a neuron&#x2013;microglia coculture to CX3CL1 reduced inflammation-related neuronal death, accompanied by suppressed nitric oxide and proinflammatory cytokine production [<xref ref-type="bibr" rid="CR118">118</xref>]. In conjunction with these findings, inhibition of endogenous CX3CL1 increased neuronal cell death in cocultures [<xref ref-type="bibr" rid="CR77">77</xref>]. Moreover, in vitro exposure to CX3CL1 supported microglia survival under basal culture conditions and reduced Fas-ligand induced apoptosis considerably [<xref ref-type="bibr" rid="CR119">119</xref>]. Thus, exposure of microglia to CX3CL1 reduced microglia toxicity and protected microglia from apoptosis under inflammatory conditions. In contrast to these results, CX3CL1 deficiency reduced the infarct volume and mortality after transient focal cerebral ischemia [<xref ref-type="bibr" rid="CR117">117</xref>]. However, microglia activity in CX3CL1-deficient and wild-type mice was not compared in this study, making it difficult to determine whether disturbed neuron&#x2013;microglia signaling was responsible for the differences [<xref ref-type="bibr" rid="CR117">117</xref>].</p>
          <p>Increased microglia toxicity by CXCR3 and its ligands CXCL10 and/or CCL21 is suggested by findings derived from the entorhinal cortex lesion (ECL) model, in which CXCR3 deficiency was associated with reduced microglia activity and reduced loss of secondary neurons in the hippocampal formation [<xref ref-type="bibr" rid="CR53">53</xref>]. An interesting aspect of chemokines in neuron&#x2013;microglia signaling is acknowledged in the ECL model. In this paper, microglia activity is specifically found within the midmolecular layer of the dentate gyrus, which is the projection site of the transected neurons (see for review, [<xref ref-type="bibr" rid="CR120">120</xref>]). The microglia activity at a site distant from the primary lesion indicates transport of the chemokine signal. Recent data reinforced this notion, showing that CCL2 that was induced in dorsal root ganglion (DRG) neurons after peripheral nerve injury was transported to afferent terminals in the spinal cord [<xref ref-type="bibr" rid="CR34">34</xref>]. Moreover, in vitro neuronal CCL21 was sorted into vesicles, transported into neuronal processes, and even reached presynaptic terminals [<xref ref-type="bibr" rid="CR46">46</xref>]. The finding of CCL21 protein in neuronal vesicles is a strong indication that neuronal chemokines may be the signals responsible for microglia activity at sites distant from the primary lesion, a phenomenon that has been observed also in humans [<xref ref-type="bibr" rid="CR121">121</xref>, <xref ref-type="bibr" rid="CR122">122</xref>].</p>
          <p>A role of CCL2 in microglia activity after neuronal death is suggested by a delayed microglia activity in the thalamus of CCL2-deficient mice in response to cortical injury [<xref ref-type="bibr" rid="CR123">123</xref>]. The delayed microglia activity was accompanied by a transient improvement of neuron survival in the thalamus, which may indicate that CCL2 is involved in neurotoxic microglia activity [<xref ref-type="bibr" rid="CR123">123</xref>]. However, it is not yet clear if this effect is due to disturbed neuron&#x2013;microglia interaction. Damaged neurons are capable to express CCL2, as was found after axotomy in sympathetic ganglia [<xref ref-type="bibr" rid="CR31">31</xref>] and facial nerve lesion [<xref ref-type="bibr" rid="CR30">30</xref>], but cortical injury predominantly induced CCL2 mRNA expression in astrocytes [<xref ref-type="bibr" rid="CR124">124</xref>]. Whether interference with CCL2 signaling would affect microglia activity in the first two models has not yet been investigated.</p>
          <p>It is clear that the assumption that neuronal chemokines are involved in neuron&#x2013;microglia signaling is no longer based on the finding that damaged neurons rapidly alter chemokine expression patterns and that microglia express the corresponding receptors [<xref ref-type="bibr" rid="CR63">63</xref>&#x2013;<xref ref-type="bibr" rid="CR65">65</xref>]. Studies now show that microglia activation is reduced in mice with genetically disturbed chemokine function, indicating an important role of chemokines in microglia activation. Recent data even suggest that neurosupportive and neurotoxic microglia activity are associated with chemokine receptor expression [<xref ref-type="bibr" rid="CR125">125</xref>]. The ultimate effects of neuronal chemokines are likely dependent on injury type, brain region, and disruption of the blood&#x2013;brain barrier [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. Whereas the exact role of neuronal chemokines in neuron&#x2013;microglia signaling remains obscure, their importance in regulating damage responses is becoming apparent.</p>
        </sec>
      </sec>
      <sec id="Sec19">
        <title>Neuron&#x2013;Neuron Interaction</title>
        <p>Various reports indicate that chemokines influence neuronal development, differentiation [<xref ref-type="bibr" rid="CR126">126</xref>, <xref ref-type="bibr" rid="CR127">127</xref>], survival [<xref ref-type="bibr" rid="CR128">128</xref>&#x2013;<xref ref-type="bibr" rid="CR130">130</xref>], electrophysiological properties [<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>], and synaptic transmission [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR92">92</xref>, <xref ref-type="bibr" rid="CR133">133</xref>]. Because neurons can express numerous chemokines, autocrine and paracrine contributions of neuronal chemokines are likely.</p>
        <sec id="Sec20">
          <title>Neuroprotection</title>
          <p>Neuronal cell death, the ultimate consequence of all neuroinflammatory conditions, has been studied extensively in vitro. However, there are relatively few in vitro models that can be extrapolated to pathological conditions leading to neuronal death in vivo. One of the most prominent models is glutamate or NMDA-induced neurotoxicity, a model for excitotoxicity, which is most likely involved in various neurodegenerative diseases. &#x3B2;-amyloid-induced neuronal death serves as a model that may explain the loss of neurons in Alzheimer&#x2019;s disease, whereas exposure of neuronal cultures to HIV proteins gp120 or HIV<sub>tat</sub> are aimed to elucidate neuronal death in HIV-dependent neurodegeneration [<xref ref-type="bibr" rid="CR134">134</xref>&#x2013;<xref ref-type="bibr" rid="CR137">137</xref>]. Several reports indicate that neuronal chemokines may protect neurons from these toxic conditions. In vitro, CX3CL1 is known to protect neurons from glutamate-induced toxicity [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR138">138</xref>], gp120-induced neuronal death [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR139">139</xref>], and death induced by deprivation of trophic support [<xref ref-type="bibr" rid="CR140">140</xref>].</p>
          <p>Similar to CX3CL1, CCL2 exposure is shown to protect neurons from glutamate- and HIV-tat-induced neurotoxicity [<xref ref-type="bibr" rid="CR141">141</xref>, <xref ref-type="bibr" rid="CR142">142</xref>]. However, CCL2 exposure was not protective in &#x3B2;-amyloid-dependent neuronal death [<xref ref-type="bibr" rid="CR141">141</xref>]. As exposure of neuronal cells to chemokines is known to activate the putatively neuroprotective MEK/ERK and PI3-K/Akt signaling pathways [<xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR138">138</xref>&#x2013;<xref ref-type="bibr" rid="CR140">140</xref>], it is reasonable to argue that chemokine-dependent protection is mediated by these pathways. Indeed, inhibition of both pathways completely abolished the neuroprotective effects of CX3CL1 in gp120- and glutamate-induced neurotoxicity in hippocampal neurons [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR78">78</xref>]. Interestingly, in case of glutamate-dependent neurotoxicity, the involvement of MEK/ERK and PI3-K/Akt signaling pathways was only evident when CX3CL1 was applied together with glutamate [<xref ref-type="bibr" rid="CR78">78</xref>]. CX3CL1 exposure was shown to be protective even when the chemokine was applied up to 8&#xA0;h after the glutamate stimulus. However, an inhibition of MEK/ERK and PI3-K/Akt pathways did not affect the protective activity of delayed CX3CL1 exposure, indicating that CX3CL1 may activate additional pathways in neurons that lead to neuroprotection [<xref ref-type="bibr" rid="CR78">78</xref>]. The effect of CXCL12 on neuronal death is contradictory. Although several reports indicate that CXCL12 exposure may protect neurons from gp120-induced neuronal death, most papers describe a toxic effect of CXCL12 in neuronal cultures (see below) [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR143">143</xref>].</p>
        </sec>
        <sec id="Sec21">
          <title>Neurotoxicity</title>
          <p>Approximately 10% of HIV-infected patients develop HIV-1 associated dementia (HAD). It has been shown that the viral protein gp120 itself is neurotoxic [<xref ref-type="bibr" rid="CR144">144</xref>], indicating that the neuronal loss in HAD is not only due to inflammation occurring after the virus enters the brain but also because of direct toxic effects of viral proteins (see for recent review, [<xref ref-type="bibr" rid="CR145">145</xref>]). It was shown in 1998 that the neurotoxic effect of gp120 is mediated via the chemokine receptor CXCR4 [<xref ref-type="bibr" rid="CR146">146</xref>], findings that have been corroborated in subsequent years by various groups [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR147">147</xref>, <xref ref-type="bibr" rid="CR148">148</xref>]. The viral protein gp120 binds and activates CXCR4, the main coreceptor utilized by HIV-1 to infect T cells. CXCR4 has subsequently become the best investigated chemokine receptor with respect to neurotoxicity, and its involvement in neurotoxic signaling has been demonstrated by use of the specific CXCR4 antagonist AMD31000 [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR147">147</xref>]. The HIV-derived protein gp120 shows agonist activity on CXCR4, and therefore, it is not surprising that its ligand CXCL12 has also been described to be neurotoxic [<xref ref-type="bibr" rid="CR102">102</xref>, <xref ref-type="bibr" rid="CR143">143</xref>, <xref ref-type="bibr" rid="CR146">146</xref>, <xref ref-type="bibr" rid="CR148">148</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. Currently, there is little information on intracellular signaling pathways that are activated by CXCR4 and subsequently lead to neuronal death. One recent report indicates the involvement of Src activity in CXCL12-induced apoptosis in a neuronal cell line, whereas gp120-induced apoptosis in these cells was independent of Src activity [<xref ref-type="bibr" rid="CR149">149</xref>]. Interestingly, CXCL12 and gp120 had different effects on ERK activation in neurons and astrocytes [<xref ref-type="bibr" rid="CR102">102</xref>], indicating that CXCR4 signaling exerts both ligand and cell-type specific effects. The effect of CXCL12 is further complicated by matrix metalloproteinase-2, which was shown to remove the first four amino acids of CXCL12, resulting in a truncated form of CXCL12 [<xref ref-type="bibr" rid="CR150">150</xref>]. This truncated form was found to be highly neurotoxic compared to the full-length CXCL12, which remarkably was not mediated by CXCR4 but by a yet unknown PTX-sensitive receptor [<xref ref-type="bibr" rid="CR150">150</xref>]. Because MMP-2 has also been described in HIV-infected patients, it is reasonable to assume that truncated CXCL12 may be a neurotoxic player in HAD [<xref ref-type="bibr" rid="CR151">151</xref>].</p>
          <p>CXCL12 is not the only neuronal chemokine that exerts neurotoxic effects. Neuronal cell lines and primary human neurons respond to high concentrations of CXCL10 with intracellular calcium transients, caspase activity, and apoptosis [<xref ref-type="bibr" rid="CR54">54</xref>, <xref ref-type="bibr" rid="CR152">152</xref>, <xref ref-type="bibr" rid="CR153">153</xref>]. The direct involvement of CXCR3 was demonstrated by the use of an antibody that prevents the activation of CXCR3 and subsequently inhibited CXCL10-dependent neurotoxicity [<xref ref-type="bibr" rid="CR153">153</xref>].</p>
        </sec>
        <sec id="Sec22">
          <title>Chemokinergic Effects on Synaptic Transmission</title>
          <p>Recent data show that CXCR4 activation by either gp120 or CXCL12 significantly enhanced giant depolarizing potentials (GDP) in rat neonatal hippocampus [<xref ref-type="bibr" rid="CR154">154</xref>]. These GDPs only occur in the developing hippocampus and are involved in growth and synapse formation. These data may explain why HIV infections have a greater impact in the developing brain than in adults [<xref ref-type="bibr" rid="CR152">152</xref>] and show that neuronal chemokines may change the electrophysiological properties of neurons, thereby corroborating earlier findings [<xref ref-type="bibr" rid="CR131">131</xref>, <xref ref-type="bibr" rid="CR132">132</xref>, <xref ref-type="bibr" rid="CR155">155</xref>, <xref ref-type="bibr" rid="CR156">156</xref>].</p>
          <p>The electrophysiological properties of neuronal chemokine receptors have predominantly been studied in cultured primary neurons or neuronal cell lines and brain slice cultures [<xref ref-type="bibr" rid="CR157">157</xref>]. Remarkably, in cultures of DRG, cerebellar granule or Purkinje neurons, and hippocampal pyramidal cells, chemokines induced changes in the electrophysiological properties of only 10&#x2013;20% of the neurons [<xref ref-type="bibr" rid="CR64">64</xref>, <xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR158">158</xref>, <xref ref-type="bibr" rid="CR159">159</xref>]. In addition, several effects of chemokines in neurons were not sensitive to PTX, in contrast to hematopoietic cells, suggesting that chemokine receptors in neurons, although generally accepted, are not solely coupled to G&#x3B1;<sub>i</sub> proteins [<xref ref-type="bibr" rid="CR128">128</xref>, <xref ref-type="bibr" rid="CR140">140</xref>, <xref ref-type="bibr" rid="CR149">149</xref>]. Whether these chemokinergic PTX-insensitive effects are mediated by neuronal G<sub>z</sub>-subunits is yet unclear [<xref ref-type="bibr" rid="CR160">160</xref>]. Cultured cerebellar and DRG neurons respond to various chemokines with intracellular calcium transients [<xref ref-type="bibr" rid="CR140">140</xref>]. In DRG neurons, exposure to CX3CL1 and CXCL12 also increased their excitability [<xref ref-type="bibr" rid="CR158">158</xref>]. Although chemokinergic effects of CX3CL1, CXCL12, CCL2, and CXCL10 in neurons have been reported to modulate the frequency of both spontaneous and activity-dependent neuronal firing, a direct effect on the induction of action potentials has not yet been described [<xref ref-type="bibr" rid="CR159">159</xref>, <xref ref-type="bibr" rid="CR161">161</xref>&#x2013;<xref ref-type="bibr" rid="CR164">164</xref>]. Similar to the effects on isolated neurons, CX3CL1, CXCL12, and CXCL10 also affected neuronal signaling in brain slice cultures [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR78">78</xref>, <xref ref-type="bibr" rid="CR91">91</xref>&#x2013;<xref ref-type="bibr" rid="CR93">93</xref>, <xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR134">134</xref>, <xref ref-type="bibr" rid="CR165">165</xref>, <xref ref-type="bibr" rid="CR166">166</xref>]. However, the presence of glia cells (astrocytes, microglia, and oligodendrocytes) in these slice cultures makes it difficult to determine whether the electrophysiological effects of chemokines are mediated by chemokine receptors on neurons and/or on glia cells, as glia cells may also induce electrophysiological changes in neurons [<xref ref-type="bibr" rid="CR26">26</xref>, <xref ref-type="bibr" rid="CR133">133</xref>, <xref ref-type="bibr" rid="CR156">156</xref>]. Whether the effects of CXCL12 in brain slice cultures are mediated via chemokine receptors on neurons and/or on glia cells may depend on the concentration, as concentrations up to 1&#xA0;nM caused a direct decrease in peak and discharge frequency of evoked action potentials in neurons and concentrations higher than 10&#xA0;nM activated an indirect GABA-mediated hyperpolarization of neurons [<xref ref-type="bibr" rid="CR92">92</xref>].</p>
        </sec>
      </sec>
    </sec>
    <sec id="Sec23">
      <title>Future Directions</title>
      <p>As discussed here, neuronal chemokines appear to be versatile messengers in CNS cell interaction. However, several important issues need to be addressed in future studies. To begin with, neuronal CX3CR1 expression in vivo remains controversial. Immunohistochemical analysis revealed CX3CR1 positive neurons in mouse brain sections with little changes under pathological conditions [<xref ref-type="bibr" rid="CR67">67</xref>], whereas neuronal CX3CR1 expression was never described in studies using genetically modified mice in which CX3CR1-expressing cells are also positive for EGFP [<xref ref-type="bibr" rid="CR116">116</xref>]. Different microscopic techniques and models of neurodegeneration have been explored in these mice, demonstrating only CX3CR1 expression in resting and activated microglia [<xref ref-type="bibr" rid="CR79">79</xref>, <xref ref-type="bibr" rid="CR105">105</xref>, <xref ref-type="bibr" rid="CR106">106</xref>, <xref ref-type="bibr" rid="CR116">116</xref>]. An explanation may be that neuronal CX3CR1 expression is at such a low level that detection is difficult to achieve with microscopic techniques. This may also be the case for CXCR3 expression in microglia. Although CXCR3 expression has yet not been described in microglia in vivo, functional evidence derived from CXCR3-deficient mice strongly indicates that microglia do express CXCR3 in vivo [<xref ref-type="bibr" rid="CR53">53</xref>, <xref ref-type="bibr" rid="CR115">115</xref>]. Therefore, it seems appropriate that future experiments concerning the expression of chemokine receptors in CNS cells in vivo also include functional analysis.</p>
      <p>Another issue that needs to be addressed in more detail regards cellular localization. Neurons are highly polarized cells, as their function is largely dependent on their morphology and contacts with other cells (e.g. synapses with other neurons). Although neuronal signaling molecules, such as neurotransmitters, neuropeptides, and neurotrophins, are generally found at specific sites, most reports describing neuronal chemokine expression did not address this issue. Interestingly, a few recent publications do suggest a localized expression of chemokines comparable to other neuronal signaling molecules. Our group demonstrated that neuronal CCL21 is transported in vesicles, reaching presynaptic terminals in cortical neurons in vitro [<xref ref-type="bibr" rid="CR46">46</xref>]. In subsequent studies, these vesicles appeared to be of the large-dense core type, in which other neuronal peptides are also found (e.g. neurotrophins; Stanulovic et al., manuscript in preparation). Moreover, it has been described for several neuronal populations in vivo that CCL2 and CXCL12 colocalize with other neurotransmitters and neuropeptides in synaptic regions [<xref ref-type="bibr" rid="CR37">37</xref>, <xref ref-type="bibr" rid="CR62">62</xref>]. Like neuronal chemokine expression, a site-specific expression of chemokine receptors may exist, as is suggested by CXCR4 redistribution in the axonal and dendritic compartment of hippocampal neurons after prolonged CXCL12 exposure [<xref ref-type="bibr" rid="CR167">167</xref>]. Because a localized expression of chemokines and their receptors may have a consequence for their role in cell interaction, future studies on neuronal chemokine expression may address this issue.</p>
      <p>At last, as all reports indicating that chemokine exposure alters the excitability of neurons used exogenous chemokines, it is yet unknown whether chemokines released from neurons have similar effects.</p>
    </sec>
    <sec id="Sec24" sec-type="conclusion">
      <title>Conclusion</title>
      <p>Knowledge on the spatial and temporal expression of neuronal chemokines and their regulation under physiological and pathological conditions is increasing rapidly. As CNS cells can express the corresponding chemokine receptors, contribution of these neuronal chemokines to CNS cell interaction is conceivable. This assumption is corroborated by various in vitro and in vivo studies. For example, the following effects of neuronal chemokines were observed in vitro: in astrocytes proliferation and migration, in microglia migration and neurotoxic and neuroprotective activity and in neurons electrophysiological changes, neurotoxicity, and neuroprotection. Further, the synaptic transmission between neurons seems to be influenced by the action of neuronal chemokines on neurons and/or glia cells. In vivo studies support the important role of chemokines in migration and neurotoxic and neuroprotective activity of microglia upon CNS injury and neuroinflammation. Further exploration of the roles of neuronal chemokines in CNS cell interaction is needful, as insight into the role of neuronal chemokines in CNS injury and neuroinflammation may contribute to the development of therapeutic strategies.</p>
    </sec>
  </body>
  <back>
    <ack>
      <title>Acknowledgment</title>
      <p>This work was supported by NWO-Vidi grant to KB, NWO-Senter grant to EkdJ and BCN grant to HRJvW. The authors would like to thank Dr. D. Chesik (UMCG, The Netherlands) for helpful discussions and editing of the manuscript.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yoshimura</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1987</year>
          <volume>84</volume>
          <fpage>9233</fpage>
          <lpage>9237</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yoshimura T (1987) Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 84:9233&#x2013;9237 <pub-id pub-id-type="pmid">3480540</pub-id></citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laing</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Chemokines</article-title>
          <source>Dev Comp Immunol</source>
          <year>2004</year>
          <volume>28</volume>
          <fpage>443</fpage>
          <lpage>460</lpage>
        </citation>
        <citation citation-type="display-unstructured">Laing KJ (2004) Chemokines. Dev Comp Immunol 28:443&#x2013;460 <pub-id pub-id-type="pmid">15062643</pub-id></citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature</article-title>
          <source>Pharmacol Rev</source>
          <year>2002</year>
          <volume>54</volume>
          <fpage>227</fpage>
          <lpage>229</lpage>
        </citation>
        <citation citation-type="display-unstructured">Murphy PM (2002) International Union of Pharmacology. XXX. Update on chemokine receptor nomenclature. Pharmacol Rev 54:227&#x2013;229 <pub-id pub-id-type="pmid">12037138</pub-id></citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Fernandez</surname>
              <given-names>EJ</given-names>
            </name>
          </person-group>
          <article-title>Structure, function, and inhibition of chemokines</article-title>
          <source>Annu Rev Pharmacol Toxicol</source>
          <year>2002</year>
          <volume>42</volume>
          <fpage>469</fpage>
          <lpage>499</lpage>
        </citation>
        <citation citation-type="display-unstructured">Fernandez EJ (2002) Structure, function, and inhibition of chemokines. Annu Rev Pharmacol Toxicol 42:469&#x2013;499 <pub-id pub-id-type="pmid">11807180</pub-id></citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rossi</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>The biology of chemokines and their receptors</article-title>
          <source>Annu Rev Immunol</source>
          <year>2000</year>
          <volume>18</volume>
          <fpage>217</fpage>
          <lpage>242</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rossi D (2000) The biology of chemokines and their receptors. Annu Rev Immunol 18:217&#x2013;242 <pub-id pub-id-type="pmid">10837058</pub-id></citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <citation citation-type="other">Biber K (2002) Neuronal SLC (CCL21) expression: implications for the neuron&#x2013;microglial signaling system. Ernst Schering Res Found Workshop 45&#x2013;60</citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dijkstra</surname>
              <given-names>IM</given-names>
            </name>
          </person-group>
          <article-title>Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21</article-title>
          <source>J Immunol</source>
          <year>2004</year>
          <volume>172</volume>
          <fpage>2744</fpage>
          <lpage>2747</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dijkstra IM (2004) Cutting edge: activity of human adult microglia in response to CC chemokine ligand 21. J Immunol 172:2744&#x2013;2747 <pub-id pub-id-type="pmid">14978072</pub-id></citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soto</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>8205</fpage>
          <lpage>8210</lpage>
        </citation>
        <citation citation-type="display-unstructured">Soto H (1998) The CC chemokine 6Ckine binds the CXC chemokine receptor CXCR3. Proc Natl Acad Sci USA 95:8205&#x2013;8210 <pub-id pub-id-type="pmid">9653165</pub-id></citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Neves</surname>
              <given-names>SR</given-names>
            </name>
          </person-group>
          <article-title>G protein pathways</article-title>
          <source>Science</source>
          <year>2002</year>
          <volume>296</volume>
          <fpage>1636</fpage>
          <lpage>1639</lpage>
        </citation>
        <citation citation-type="display-unstructured">Neves SR (2002) G protein pathways. Science 296:1636&#x2013;1639 <pub-id pub-id-type="pmid">12040175</pub-id></citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murphy</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Chemokine receptors: structure, function and role in microbial pathogenesis</article-title>
          <source>Cytokine Growth Factor Rev</source>
          <year>1996</year>
          <volume>7</volume>
          <fpage>47</fpage>
          <lpage>64</lpage>
        </citation>
        <citation citation-type="display-unstructured">Murphy PM (1996) Chemokine receptors: structure, function and role in microbial pathogenesis. Cytokine Growth Factor Rev 7:47&#x2013;64 <pub-id pub-id-type="pmid">8864354</pub-id></citation>
      </ref>
      <ref id="CR11">
        <label>11.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Balkwill</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The molecular and cellular biology of the chemokines</article-title>
          <source>J Viral Hepat</source>
          <year>1998</year>
          <volume>5</volume>
          <fpage>1</fpage>
          <lpage>14</lpage>
        </citation>
        <citation citation-type="display-unstructured">Balkwill F (1998) The molecular and cellular biology of the chemokines. J Viral Hepat 5:1&#x2013;14 <pub-id pub-id-type="pmid">9493511</pub-id></citation>
      </ref>
      <ref id="CR12">
        <label>12.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mellado</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Chemokine receptor homo- or heterodimerization activates distinct signaling pathways</article-title>
          <source>EMBO J</source>
          <year>2001</year>
          <volume>20</volume>
          <fpage>2497</fpage>
          <lpage>2507</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mellado M (2001) Chemokine receptor homo- or heterodimerization activates distinct signaling pathways. EMBO J 20:2497&#x2013;2507 <pub-id pub-id-type="pmid">11350939</pub-id></citation>
      </ref>
      <ref id="CR13">
        <label>13.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Laudanna</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes</article-title>
          <source>Thromb Haemost</source>
          <year>2006</year>
          <volume>95</volume>
          <fpage>5</fpage>
          <lpage>11</lpage>
        </citation>
        <citation citation-type="display-unstructured">Laudanna C (2006) Right on the spot. Chemokine triggering of integrin-mediated arrest of rolling leukocytes. Thromb Haemost 95:5&#x2013;11 <pub-id pub-id-type="pmid">16543955</pub-id></citation>
      </ref>
      <ref id="CR14">
        <label>14.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rittner</surname>
              <given-names>HL</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and pain</article-title>
          <source>Curr Opin Investig Drugs</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>643</fpage>
          <lpage>646</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rittner HL (2006) Chemokines and pain. Curr Opin Investig Drugs 7:643&#x2013;646 <pub-id pub-id-type="pmid">16869118</pub-id></citation>
      </ref>
      <ref id="CR15">
        <label>15.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baggiolini</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and leukocyte traffic</article-title>
          <source>Nature</source>
          <year>1998</year>
          <volume>392</volume>
          <fpage>565</fpage>
          <lpage>568</lpage>
        </citation>
        <citation citation-type="display-unstructured">Baggiolini M (1998) Chemokines and leukocyte traffic. Nature 392:565&#x2013;568 <pub-id pub-id-type="pmid">9560152</pub-id></citation>
      </ref>
      <ref id="CR16">
        <label>16.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Moser</surname>
              <given-names>B</given-names>
            </name>
          </person-group>
          <article-title>Lymphocyte traffic control by chemokines</article-title>
          <source>Nat Immunol</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>123</fpage>
          <lpage>128</lpage>
        </citation>
        <citation citation-type="display-unstructured">Moser B (2001) Lymphocyte traffic control by chemokines. Nat Immunol 2:123&#x2013;128 <pub-id pub-id-type="pmid">11175804</pub-id></citation>
      </ref>
      <ref id="CR17">
        <label>17.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rot</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells</article-title>
          <source>Annu Rev Immunol</source>
          <year>2004</year>
          <volume>22</volume>
          <fpage>891</fpage>
          <lpage>928</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rot A (2004) Chemokines in innate and adaptive host defense: basic chemokinese grammar for immune cells. Annu Rev Immunol 22:891&#x2013;928 <pub-id pub-id-type="pmid">15032599</pub-id></citation>
      </ref>
      <ref id="CR18">
        <label>18.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Benelli</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Cytokines and chemokines as regulators of angiogenesis in health and disease</article-title>
          <source>Curr Pharm Des</source>
          <year>2006</year>
          <volume>12</volume>
          <fpage>3101</fpage>
          <lpage>3115</lpage>
        </citation>
        <citation citation-type="display-unstructured">Benelli R (2006) Cytokines and chemokines as regulators of angiogenesis in health and disease. Curr Pharm Des 12:3101&#x2013;3115 <pub-id pub-id-type="pmid">16918437</pub-id></citation>
      </ref>
      <ref id="CR19">
        <label>19.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Charo</surname>
              <given-names>IF</given-names>
            </name>
          </person-group>
          <article-title>The many roles of chemokines and chemokine receptors in inflammation</article-title>
          <source>N Engl J Med</source>
          <year>2006</year>
          <volume>354</volume>
          <fpage>610</fpage>
          <lpage>621</lpage>
        </citation>
        <citation citation-type="display-unstructured">Charo IF (2006) The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354:610&#x2013;621 <pub-id pub-id-type="pmid">16467548</pub-id></citation>
      </ref>
      <ref id="CR20">
        <label>20.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kunkel</surname>
              <given-names>SL</given-names>
            </name>
          </person-group>
          <article-title>Through the looking glass: the diverse in vivo activities of chemokines</article-title>
          <source>J Clin Invest</source>
          <year>1999</year>
          <volume>104</volume>
          <fpage>1333</fpage>
          <lpage>1334</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kunkel SL (1999) Through the looking glass: the diverse in vivo activities of chemokines. J Clin Invest 104:1333&#x2013;1334 <pub-id pub-id-type="pmid">10562292</pub-id></citation>
      </ref>
      <ref id="CR21">
        <label>21.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mackay</surname>
              <given-names>CR</given-names>
            </name>
          </person-group>
          <article-title>Chemokines: immunology&#x2019;s high impact factors</article-title>
          <source>Nat Immunol</source>
          <year>2001</year>
          <volume>2</volume>
          <fpage>95</fpage>
          <lpage>101</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mackay CR (2001) Chemokines: immunology&#x2019;s high impact factors. Nat Immunol 2:95&#x2013;101 <pub-id pub-id-type="pmid">11175800</pub-id></citation>
      </ref>
      <ref id="CR22">
        <label>22.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Murray</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Role of chemokines in severe asthma</article-title>
          <source>Curr Drug Targets</source>
          <year>2006</year>
          <volume>7</volume>
          <fpage>579</fpage>
          <lpage>588</lpage>
        </citation>
        <citation citation-type="display-unstructured">Murray LA (2006) Role of chemokines in severe asthma. Curr Drug Targets 7:579&#x2013;588 <pub-id pub-id-type="pmid">16719768</pub-id></citation>
      </ref>
      <ref id="CR23">
        <label>23.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pease</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and their receptors in allergic disease</article-title>
          <source>J Allergy Clin Immunol</source>
          <year>2006</year>
          <volume>118</volume>
          <fpage>305</fpage>
          <lpage>318</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pease JE (2006) Chemokines and their receptors in allergic disease. J Allergy Clin Immunol 118:305&#x2013;318 <pub-id pub-id-type="pmid">16890751</pub-id></citation>
      </ref>
      <ref id="CR24">
        <label>24.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zlotnik</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Involvement of chemokine receptors in organ-specific metastasis</article-title>
          <source>Contrib Microbiol</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>191</fpage>
          <lpage>199</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zlotnik A (2006) Involvement of chemokine receptors in organ-specific metastasis. Contrib Microbiol 13:191&#x2013;199 <pub-id pub-id-type="pmid">16627966</pub-id></citation>
      </ref>
      <ref id="CR25">
        <label>25.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ubogu</surname>
              <given-names>EE</given-names>
            </name>
          </person-group>
          <article-title>The expression and function of chemokines involved in CNS inflammation</article-title>
          <source>Trends Pharmacol Sci</source>
          <year>2006</year>
          <volume>27</volume>
          <fpage>48</fpage>
          <lpage>55</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ubogu EE (2006) The expression and function of chemokines involved in CNS inflammation. Trends Pharmacol Sci 27:48&#x2013;55 <pub-id pub-id-type="pmid">16310865</pub-id></citation>
      </ref>
      <ref id="CR26">
        <label>26.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bertollini</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine/CX(3)CL1 depresses central synaptic transmission in mouse hippocampal slices</article-title>
          <source>Neuropharmacology</source>
          <year>2006</year>
          <volume>51</volume>
          <fpage>816</fpage>
          <lpage>821</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bertollini C (2006) Fractalkine/CX(3)CL1 depresses central synaptic transmission in mouse hippocampal slices. Neuropharmacology 51:816&#x2013;821 <pub-id pub-id-type="pmid">16815480</pub-id></citation>
      </ref>
      <ref id="CR27">
        <label>27.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Che</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice</article-title>
          <source>Brain Res</source>
          <year>2001</year>
          <volume>902</volume>
          <fpage>171</fpage>
          <lpage>177</lpage>
        </citation>
        <citation citation-type="display-unstructured">Che X (2001) Monocyte chemoattractant protein-1 expressed in neurons and astrocytes during focal ischemia in mice. Brain Res 902:171&#x2013;177 <pub-id pub-id-type="pmid">11384610</pub-id></citation>
      </ref>
      <ref id="CR28">
        <label>28.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ivacko</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>1997</year>
          <volume>17</volume>
          <fpage>759</fpage>
          <lpage>770</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ivacko J (1997) Hypoxic-ischemic injury induces monocyte chemoattractant protein-1 expression in neonatal rat brain. J Cereb Blood Flow Metab 17:759&#x2013;770 <pub-id pub-id-type="pmid">9270493</pub-id></citation>
      </ref>
      <ref id="CR29">
        <label>29.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pang</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression</article-title>
          <source>Stroke</source>
          <year>2001</year>
          <volume>32</volume>
          <fpage>544</fpage>
          <lpage>552</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pang L (2001) Reduction of inflammatory response in the mouse brain with adenoviral-mediated transforming growth factor-ss1 expression. Stroke 32:544&#x2013;552 <pub-id pub-id-type="pmid">11157195</pub-id></citation>
      </ref>
      <ref id="CR30">
        <label>30.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flugel</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Neuronal MCP-1 expression in response to remote nerve injury</article-title>
          <source>J Cereb Blood Flow Metab</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>69</fpage>
          <lpage>76</lpage>
        </citation>
        <citation citation-type="display-unstructured">Flugel A (2001) Neuronal MCP-1 expression in response to remote nerve injury. J Cereb Blood Flow Metab 21:69&#x2013;76 <pub-id pub-id-type="pmid">11149670</pub-id></citation>
      </ref>
      <ref id="CR31">
        <label>31.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schreiber</surname>
              <given-names>RC</given-names>
            </name>
          </person-group>
          <article-title>Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury</article-title>
          <source>Neuroreport</source>
          <year>2001</year>
          <volume>12</volume>
          <fpage>601</fpage>
          <lpage>606</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schreiber RC (2001) Monocyte chemoattractant protein (MCP)-1 is rapidly expressed by sympathetic ganglion neurons following axonal injury. Neuroreport 12:601&#x2013;606 <pub-id pub-id-type="pmid">11234772</pub-id></citation>
      </ref>
      <ref id="CR32">
        <label>32.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanaka</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain</article-title>
          <source>Neurosci Res</source>
          <year>2004</year>
          <volume>48</volume>
          <fpage>463</fpage>
          <lpage>469</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tanaka T (2004) Enhanced production of monocyte chemoattractant protein-1 in the dorsal root ganglia in a rat model of neuropathic pain: possible involvement in the development of neuropathic pain. Neurosci Res 48:463&#x2013;469 <pub-id pub-id-type="pmid">15041200</pub-id></citation>
      </ref>
      <ref id="CR33">
        <label>33.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>White</surname>
              <given-names>FA</given-names>
            </name>
          </person-group>
          <article-title>Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2005</year>
          <volume>102</volume>
          <fpage>14092</fpage>
          <lpage>14097</lpage>
        </citation>
        <citation citation-type="display-unstructured">White FA (2005) Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. Proc Natl Acad Sci USA 102:14092&#x2013;14097 <pub-id pub-id-type="pmid">16174730</pub-id></citation>
      </ref>
      <ref id="CR34">
        <label>34.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury</article-title>
          <source>J Neurochem</source>
          <year>2006</year>
          <volume>97</volume>
          <fpage>772</fpage>
          <lpage>783</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zhang J (2006) Spatial and temporal relationship between monocyte chemoattractant protein-1 expression and spinal glial activation following peripheral nerve injury. J Neurochem 97:772&#x2013;783 <pub-id pub-id-type="pmid">16524371</pub-id></citation>
      </ref>
      <ref id="CR35">
        <label>35.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baron</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis</article-title>
          <source>Muscle Nerve</source>
          <year>2005</year>
          <volume>32</volume>
          <fpage>541</fpage>
          <lpage>544</lpage>
        </citation>
        <citation citation-type="display-unstructured">Baron P (2005) Production of monocyte chemoattractant protein-1 in amyotrophic lateral sclerosis. Muscle Nerve 32:541&#x2013;544 <pub-id pub-id-type="pmid">15962273</pub-id></citation>
      </ref>
      <ref id="CR36">
        <label>36.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Henkel</surname>
              <given-names>JS</given-names>
            </name>
          </person-group>
          <article-title>The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2006</year>
          <volume>31</volume>
          <fpage>427</fpage>
          <lpage>437</lpage>
        </citation>
        <citation citation-type="display-unstructured">Henkel JS (2006) The chemokine MCP-1 and the dendritic and myeloid cells it attracts are increased in the mSOD1 mouse model of ALS. Mol Cell Neurosci 31:427&#x2013;437 <pub-id pub-id-type="pmid">16337133</pub-id></citation>
      </ref>
      <ref id="CR37">
        <label>37.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banisadr</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides</article-title>
          <source>J Comp Neurol</source>
          <year>2005</year>
          <volume>489</volume>
          <fpage>275</fpage>
          <lpage>292</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banisadr G (2005) Highly regionalized neuronal expression of monocyte chemoattractant protein-1 (MCP-1/CCL2) in rat brain: evidence for its colocalization with neurotransmitters and neuropeptides. J Comp Neurol 489:275&#x2013;292 <pub-id pub-id-type="pmid">16025454</pub-id></citation>
      </ref>
      <ref id="CR38">
        <label>38.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Coughlan</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons</article-title>
          <source>Neuroscience</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>591</fpage>
          <lpage>600</lpage>
        </citation>
        <citation citation-type="display-unstructured">Coughlan CM (2000) Expression of multiple functional chemokine receptors and monocyte chemoattractant protein-1 in human neurons. Neuroscience 97:591&#x2013;600 <pub-id pub-id-type="pmid">10828541</pub-id></citation>
      </ref>
      <ref id="CR39">
        <label>39.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meng</surname>
              <given-names>SZ</given-names>
            </name>
          </person-group>
          <article-title>Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem</article-title>
          <source>Brain Dev</source>
          <year>1999</year>
          <volume>21</volume>
          <fpage>30</fpage>
          <lpage>35</lpage>
        </citation>
        <citation citation-type="display-unstructured">Meng SZ (1999) Developmental expression of monocyte chemoattractant protein-1 in the human cerebellum and brainstem. Brain Dev 21:30&#x2013;35 <pub-id pub-id-type="pmid">10082250</pub-id></citation>
      </ref>
      <ref id="CR40">
        <label>40.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xia</surname>
              <given-names>MQ</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer&#x2019;s disease brains</article-title>
          <source>Am J Pathol</source>
          <year>1998</year>
          <volume>153</volume>
          <fpage>31</fpage>
          <lpage>37</lpage>
        </citation>
        <citation citation-type="display-unstructured">Xia MQ (1998) Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer&#x2019;s disease brains. Am J Pathol 153:31&#x2013;37 <pub-id pub-id-type="pmid">9665462</pub-id></citation>
      </ref>
      <ref id="CR41">
        <label>41.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bakhiet</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>RANTES promotes growth and survival of human first-trimester forebrain astrocytes</article-title>
          <source>Nat Cell Biol</source>
          <year>2001</year>
          <volume>3</volume>
          <fpage>150</fpage>
          <lpage>157</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bakhiet M (2001) RANTES promotes growth and survival of human first-trimester forebrain astrocytes. Nat Cell Biol 3:150&#x2013;157 <pub-id pub-id-type="pmid">11175747</pub-id></citation>
      </ref>
      <ref id="CR42">
        <label>42.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schluter</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of <italic>T. gondii</italic></article-title>
          <source>Infect Immun</source>
          <year>2001</year>
          <volume>69</volume>
          <fpage>7889</fpage>
          <lpage>7893</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schluter D (2001) Toxoplasma gondii infection of neurons induces neuronal cytokine and chemokine production, but gamma interferon- and tumor necrosis factor-stimulated neurons fail to inhibit the invasion and growth of T. gondii. Infect Immun 69:7889&#x2013;7893 <pub-id pub-id-type="pmid">11705972</pub-id></citation>
      </ref>
      <ref id="CR43">
        <label>43.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis</article-title>
          <source>J Virol</source>
          <year>2005</year>
          <volume>79</volume>
          <fpage>11457</fpage>
          <lpage>11466</lpage>
        </citation>
        <citation citation-type="display-unstructured">Klein RS (2005) Neuronal CXCL10 directs CD8+ T-cell recruitment and control of West Nile virus encephalitis. J Virol 79:11457&#x2013;11466 <pub-id pub-id-type="pmid">16103196</pub-id></citation>
      </ref>
      <ref id="CR44">
        <label>44.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Patterson</surname>
              <given-names>CE</given-names>
            </name>
          </person-group>
          <article-title>Measles virus infection induces chemokine synthesis by neurons</article-title>
          <source>J Immunol</source>
          <year>2003</year>
          <volume>171</volume>
          <fpage>3102</fpage>
          <lpage>3109</lpage>
        </citation>
        <citation citation-type="display-unstructured">Patterson CE (2003) Measles virus infection induces chemokine synthesis by neurons. J Immunol 171:3102&#x2013;3109 <pub-id pub-id-type="pmid">12960336</pub-id></citation>
      </ref>
      <ref id="CR45">
        <label>45.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC)</article-title>
          <source>Glia</source>
          <year>2001</year>
          <volume>34</volume>
          <fpage>121</fpage>
          <lpage>133</lpage>
        </citation>
        <citation citation-type="display-unstructured">Biber K (2001) Ischemia-induced neuronal expression of the microglia attracting chemokine Secondary Lymphoid-tissue Chemokine (SLC). Glia 34:121&#x2013;133 <pub-id pub-id-type="pmid">11307161</pub-id></citation>
      </ref>
      <ref id="CR46">
        <label>46.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jong</surname>
              <given-names>EK</given-names>
            </name>
          </person-group>
          <article-title>Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion</article-title>
          <source>J Neurosci</source>
          <year>2005</year>
          <volume>25</volume>
          <fpage>7548</fpage>
          <lpage>7557</lpage>
        </citation>
        <citation citation-type="display-unstructured">de Jong EK (2005) Vesicle-mediated transport and release of CCL21 in endangered neurons: a possible explanation for microglia activation remote from a primary lesion. J Neurosci 25:7548&#x2013;7557 <pub-id pub-id-type="pmid">16107642</pub-id></citation>
      </ref>
      <ref id="CR47">
        <label>47.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muller</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development</article-title>
          <source>Curr Opin Immunol</source>
          <year>2003</year>
          <volume>15</volume>
          <fpage>217</fpage>
          <lpage>224</lpage>
        </citation>
        <citation citation-type="display-unstructured">Muller G (2003) Concerted action of the chemokine and lymphotoxin system in secondary lymphoid-organ development. Curr Opin Immunol 15:217&#x2013;224 <pub-id pub-id-type="pmid">12633673</pub-id></citation>
      </ref>
      <ref id="CR48">
        <label>48.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Aloisi</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Lymphoid neogenesis in chronic inflammatory diseases</article-title>
          <source>Nat Rev Immunol</source>
          <year>2006</year>
          <volume>6</volume>
          <fpage>205</fpage>
          <lpage>217</lpage>
        </citation>
        <citation citation-type="display-unstructured">Aloisi F (2006) Lymphoid neogenesis in chronic inflammatory diseases. Nat Rev Immunol 6:205&#x2013;217 <pub-id pub-id-type="pmid">16498451</pub-id></citation>
      </ref>
      <ref id="CR49">
        <label>49.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>1009</fpage>
          <lpage>1017</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen SC (2002) Central nervous system inflammation and neurological disease in transgenic mice expressing the CC chemokine CCL21 in oligodendrocytes. J Immunol 168:1009&#x2013;1017 <pub-id pub-id-type="pmid">11801633</pub-id></citation>
      </ref>
      <ref id="CR50">
        <label>50.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>SC</given-names>
            </name>
          </person-group>
          <article-title>Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>1001</fpage>
          <lpage>1008</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen SC (2002) Ectopic expression of the murine chemokines CCL21a and CCL21b induces the formation of lymph node-like structures in pancreas, but not skin, of transgenic mice. J Immunol 168:1001&#x2013;1008 <pub-id pub-id-type="pmid">11801632</pub-id></citation>
      </ref>
      <ref id="CR51">
        <label>51.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Yabe</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Treatment of cerebellar granule cell neurons with the neurotrophic factor pigment epithelium-derived factor in vitro enhances expression of other neurotrophic factors as well as cytokines and chemokines</article-title>
          <source>J Neurosci Res</source>
          <year>2004</year>
          <volume>77</volume>
          <fpage>642</fpage>
          <lpage>652</lpage>
        </citation>
        <citation citation-type="display-unstructured">Yabe T (2004) Treatment of cerebellar granule cell neurons with the neurotrophic factor pigment epithelium-derived factor in vitro enhances expression of other neurotrophic factors as well as cytokines and chemokines. J Neurosci Res 77:642&#x2013;652 <pub-id pub-id-type="pmid">15352210</pub-id></citation>
      </ref>
      <ref id="CR52">
        <label>52.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Wang</surname>
              <given-names>X</given-names>
            </name>
          </person-group>
          <article-title>Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat</article-title>
          <source>J Neurochem</source>
          <year>1998</year>
          <volume>71</volume>
          <fpage>1194</fpage>
          <lpage>1204</lpage>
        </citation>
        <citation citation-type="display-unstructured">Wang X (1998) Prolonged expression of interferon-inducible protein-10 in ischemic cortex after permanent occlusion of the middle cerebral artery in rat. J Neurochem 71:1194&#x2013;1204 <pub-id pub-id-type="pmid">9721745</pub-id></citation>
      </ref>
      <ref id="CR53">
        <label>53.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rappert</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion</article-title>
          <source>J Neurosci</source>
          <year>2004</year>
          <volume>24</volume>
          <fpage>8500</fpage>
          <lpage>8509</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rappert A (2004) CXCR3-dependent microglial recruitment is essential for dendrite loss after brain lesion. J Neurosci 24:8500&#x2013;8509 <pub-id pub-id-type="pmid">15456824</pub-id></citation>
      </ref>
      <ref id="CR54">
        <label>54.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sui</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis</article-title>
          <source>Am J Pathol</source>
          <year>2004</year>
          <volume>164</volume>
          <fpage>1557</fpage>
          <lpage>1566</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sui Y (2004) Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol 164:1557&#x2013;1566 <pub-id pub-id-type="pmid">15111302</pub-id></citation>
      </ref>
      <ref id="CR55">
        <label>55.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gleichmann</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system</article-title>
          <source>Eur J Neurosci</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>1857</fpage>
          <lpage>1866</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gleichmann M (2000) Cloning and characterization of SDF-1gamma, a novel SDF-1 chemokine transcript with developmentally regulated expression in the nervous system. Eur J Neurosci 12:1857&#x2013;1866 <pub-id pub-id-type="pmid">10886327</pub-id></citation>
      </ref>
      <ref id="CR56">
        <label>56.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Stumm</surname>
              <given-names>RK</given-names>
            </name>
          </person-group>
          <article-title>A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia</article-title>
          <source>J Neurosci</source>
          <year>2002</year>
          <volume>22</volume>
          <fpage>5865</fpage>
          <lpage>5878</lpage>
        </citation>
        <citation citation-type="display-unstructured">Stumm RK (2002) A dual role for the SDF-1/CXCR4 chemokine receptor system in adult brain: isoform-selective regulation of SDF-1 expression modulates CXCR4-dependent neuronal plasticity and cerebral leukocyte recruitment after focal ischemia. J Neurosci 22:5865&#x2013;5878 <pub-id pub-id-type="pmid">12122049</pub-id></citation>
      </ref>
      <ref id="CR57">
        <label>57.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bajetto</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1</article-title>
          <source>J Neurochem</source>
          <year>1999</year>
          <volume>73</volume>
          <fpage>2348</fpage>
          <lpage>2357</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bajetto A (1999) Glial and neuronal cells express functional chemokine receptor CXCR4 and its natural ligand stromal cell-derived factor 1. J Neurochem 73:2348&#x2013;2357 <pub-id pub-id-type="pmid">10582593</pub-id></citation>
      </ref>
      <ref id="CR58">
        <label>58.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ohtani</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells</article-title>
          <source>Neurosci Lett</source>
          <year>1998</year>
          <volume>249</volume>
          <fpage>163</fpage>
          <lpage>166</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ohtani Y (1998) Expression of stromal cell-derived factor-1 and CXCR4 chemokine receptor mRNAs in cultured rat glial and neuronal cells. Neurosci Lett 249:163&#x2013;166 <pub-id pub-id-type="pmid">9682842</pub-id></citation>
      </ref>
      <ref id="CR59">
        <label>59.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rostasy</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>617</fpage>
          <lpage>626</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rostasy K (2003) SDF-1alpha is expressed in astrocytes and neurons in the AIDS dementia complex: an in vivo and in vitro study. J Neuropathol Exp Neurol 62:617&#x2013;626 <pub-id pub-id-type="pmid">12834106</pub-id></citation>
      </ref>
      <ref id="CR60">
        <label>60.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tham</surname>
              <given-names>TN</given-names>
            </name>
          </person-group>
          <article-title>Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system</article-title>
          <source>Eur J Neurosci</source>
          <year>2001</year>
          <volume>13</volume>
          <fpage>845</fpage>
          <lpage>856</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tham TN (2001) Developmental pattern of expression of the alpha chemokine stromal cell-derived factor 1 in the rat central nervous system. Eur J Neurosci 13:845&#x2013;856 <pub-id pub-id-type="pmid">11264658</pub-id></citation>
      </ref>
      <ref id="CR61">
        <label>61.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banisadr</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons</article-title>
          <source>Eur J Neurosci</source>
          <year>2003</year>
          <volume>18</volume>
          <fpage>1593</fpage>
          <lpage>1606</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banisadr G (2003) Highly regionalized distribution of stromal cell-derived factor-1/CXCL12 in adult rat brain: constitutive expression in cholinergic, dopaminergic and vasopressinergic neurons. Eur J Neurosci 18:1593&#x2013;1606 <pub-id pub-id-type="pmid">14511338</pub-id></citation>
      </ref>
      <ref id="CR62">
        <label>62.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Callewaere</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2006</year>
          <volume>103</volume>
          <fpage>8221</fpage>
          <lpage>8226</lpage>
        </citation>
        <citation citation-type="display-unstructured">Callewaere C (2006) The chemokine SDF-1/CXCL12 modulates the firing pattern of vasopressin neurons and counteracts induced vasopressin release through CXCR4. Proc Natl Acad Sci USA 103:8221&#x2013;8226 <pub-id pub-id-type="pmid">16702540</pub-id></citation>
      </ref>
      <ref id="CR63">
        <label>63.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Harrison</surname>
              <given-names>JK</given-names>
            </name>
          </person-group>
          <article-title>Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>10896</fpage>
          <lpage>10901</lpage>
        </citation>
        <citation citation-type="display-unstructured">Harrison JK (1998) Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proc Natl Acad Sci U S A 95:10896&#x2013;10901 <pub-id pub-id-type="pmid">9724801</pub-id></citation>
      </ref>
      <ref id="CR64">
        <label>64.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1998</year>
          <volume>95</volume>
          <fpage>14500</fpage>
          <lpage>14505</lpage>
        </citation>
        <citation citation-type="display-unstructured">Meucci O (1998) Chemokines regulate hippocampal neuronal signaling and gp120 neurotoxicity. Proc Natl Acad Sci USA 95:14500&#x2013;14505 <pub-id pub-id-type="pmid">9826729</pub-id></citation>
      </ref>
      <ref id="CR65">
        <label>65.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nishiyori</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia?</article-title>
          <source>FEBS Lett</source>
          <year>1998</year>
          <volume>429</volume>
          <fpage>167</fpage>
          <lpage>172</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nishiyori A (1998) Localization of fractalkine and CX3CR1 mRNAs in rat brain: does fractalkine play a role in signaling from neuron to microglia? FEBS Lett 429:167&#x2013;172 <pub-id pub-id-type="pmid">9650583</pub-id></citation>
      </ref>
      <ref id="CR66">
        <label>66.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Schwaeble</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Neuronal expression of fractalkine in the presence and absence of inflammation</article-title>
          <source>FEBS Lett</source>
          <year>1998</year>
          <volume>439</volume>
          <fpage>203</fpage>
          <lpage>207</lpage>
        </citation>
        <citation citation-type="display-unstructured">Schwaeble WJ (1998) Neuronal expression of fractalkine in the presence and absence of inflammation. FEBS Lett 439:203&#x2013;207 <pub-id pub-id-type="pmid">9845323</pub-id></citation>
      </ref>
      <ref id="CR67">
        <label>67.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hughes</surname>
              <given-names>PM</given-names>
            </name>
          </person-group>
          <article-title>Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS</article-title>
          <source>Glia</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>314</fpage>
          <lpage>327</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hughes PM (2002) Expression of fractalkine (CX3CL1) and its receptor, CX3CR1, during acute and chronic inflammation in the rodent CNS. Glia 37:314&#x2013;327 <pub-id pub-id-type="pmid">11870871</pub-id></citation>
      </ref>
      <ref id="CR68">
        <label>68.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sunnemark</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin</article-title>
          <source>J Neuroinflammation</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>17</fpage>
        </citation>
        <citation citation-type="display-unstructured">Sunnemark D (2005) CX3CL1 (fractalkine) and CX3CR1 expression in myelin oligodendrocyte glycoprotein-induced experimental autoimmune encephalomyelitis: kinetics and cellular origin. J Neuroinflammation 2:17 <pub-id pub-id-type="pmid">16053521</pub-id></citation>
      </ref>
      <ref id="CR69">
        <label>69.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarozzo</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine protein localization and gene expression in mouse brain</article-title>
          <source>J Neurosci Res</source>
          <year>2003</year>
          <volume>73</volume>
          <fpage>81</fpage>
          <lpage>88</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tarozzo G (2003) Fractalkine protein localization and gene expression in mouse brain. J Neurosci Res 73:81&#x2013;88 <pub-id pub-id-type="pmid">12815711</pub-id></citation>
      </ref>
      <ref id="CR70">
        <label>70.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pan</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation</article-title>
          <source>Nature</source>
          <year>1997</year>
          <volume>387</volume>
          <fpage>611</fpage>
          <lpage>617</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pan Y (1997) Neurotactin, a membrane-anchored chemokine upregulated in brain inflammation. Nature 387:611&#x2013;617 <pub-id pub-id-type="pmid">9177350</pub-id></citation>
      </ref>
      <ref id="CR71">
        <label>71.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Garton</surname>
              <given-names>KJ</given-names>
            </name>
          </person-group>
          <article-title>Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1)</article-title>
          <source>J Biol Chem</source>
          <year>2001</year>
          <volume>276</volume>
          <fpage>37993</fpage>
          <lpage>38001</lpage>
        </citation>
        <citation citation-type="display-unstructured">Garton KJ (2001) Tumor necrosis factor-alpha-converting enzyme (ADAM17) mediates the cleavage and shedding of fractalkine (CX3CL1). J Biol Chem 276:37993&#x2013;38001 <pub-id pub-id-type="pmid">11495925</pub-id></citation>
      </ref>
      <ref id="CR72">
        <label>72.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hundhausen</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell&#x2013;cell adhesion</article-title>
          <source>Blood</source>
          <year>2003</year>
          <volume>102</volume>
          <fpage>1186</fpage>
          <lpage>1195</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hundhausen C (2003) The disintegrin-like metalloproteinase ADAM10 is involved in constitutive cleavage of CX3CL1 (fractalkine) and regulates CX3CL1-mediated cell&#x2013;cell adhesion. Blood 102:1186&#x2013;1195 <pub-id pub-id-type="pmid">12714508</pub-id></citation>
      </ref>
      <ref id="CR73">
        <label>73.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chapman</surname>
              <given-names>GA</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage</article-title>
          <source>J Neurosci</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>RC87</fpage>
        </citation>
        <citation citation-type="display-unstructured">Chapman GA (2000) Fractalkine cleavage from neuronal membranes represents an acute event in the inflammatory response to excitotoxic brain damage. J Neurosci 20:RC87 <pub-id pub-id-type="pmid">10899174</pub-id></citation>
      </ref>
      <ref id="CR74">
        <label>74.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Erichsen</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia</article-title>
          <source>J Neuroimmunol</source>
          <year>2003</year>
          <volume>138</volume>
          <fpage>144</fpage>
          <lpage>155</lpage>
        </citation>
        <citation citation-type="display-unstructured">Erichsen D (2003) Neuronal injury regulates fractalkine: relevance for HIV-1 associated dementia. J Neuroimmunol 138:144&#x2013;155 <pub-id pub-id-type="pmid">12742664</pub-id></citation>
      </ref>
      <ref id="CR75">
        <label>75.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hatori</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine and fractalkine receptors in human neurons and glial cells</article-title>
          <source>J Neurosci Res</source>
          <year>2002</year>
          <volume>69</volume>
          <fpage>418</fpage>
          <lpage>426</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hatori K (2002) Fractalkine and fractalkine receptors in human neurons and glial cells. J Neurosci Res 69:418&#x2013;426 <pub-id pub-id-type="pmid">12125082</pub-id></citation>
      </ref>
      <ref id="CR76">
        <label>76.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Maciejewski-Lenoir</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia</article-title>
          <source>J Immunol</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>1628</fpage>
          <lpage>1635</lpage>
        </citation>
        <citation citation-type="display-unstructured">Maciejewski-Lenoir D (1999) Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia. J Immunol 163:1628&#x2013;1635 <pub-id pub-id-type="pmid">10415068</pub-id></citation>
      </ref>
      <ref id="CR77">
        <label>77.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mizuno</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Production and neuroprotective functions of fractalkine in the central nervous system</article-title>
          <source>Brain Res</source>
          <year>2003</year>
          <volume>979</volume>
          <fpage>65</fpage>
          <lpage>70</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mizuno T (2003) Production and neuroprotective functions of fractalkine in the central nervous system. Brain Res 979:65&#x2013;70 <pub-id pub-id-type="pmid">12850572</pub-id></citation>
      </ref>
      <ref id="CR78">
        <label>78.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Limatola</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity</article-title>
          <source>J Neuroimmunol</source>
          <year>2005</year>
          <volume>166</volume>
          <fpage>19</fpage>
          <lpage>28</lpage>
        </citation>
        <citation citation-type="display-unstructured">Limatola C (2005) Chemokine CX3CL1 protects rat hippocampal neurons against glutamate-mediated excitotoxicity. J Neuroimmunol 166:19&#x2013;28 <pub-id pub-id-type="pmid">16019082</pub-id></citation>
      </ref>
      <ref id="CR79">
        <label>79.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cardona</surname>
              <given-names>AE</given-names>
            </name>
          </person-group>
          <article-title>Control of microglial neurotoxicity by the fractalkine receptor</article-title>
          <source>Nat Neurosci</source>
          <year>2006</year>
          <volume>9</volume>
          <fpage>917</fpage>
          <lpage>924</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cardona AE (2006) Control of microglial neurotoxicity by the fractalkine receptor. Nat Neurosci 9:917&#x2013;924 <pub-id pub-id-type="pmid">16732273</pub-id></citation>
      </ref>
      <ref id="CR80">
        <label>80.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Volterra</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Astrocytes, from brain glue to communication elements: the revolution continues</article-title>
          <source>Nat Rev Neurosci</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>626</fpage>
          <lpage>640</lpage>
        </citation>
        <citation citation-type="display-unstructured">Volterra A (2005) Astrocytes, from brain glue to communication elements: the revolution continues. Nat Rev Neurosci 6:626&#x2013;640 <pub-id pub-id-type="pmid">16025096</pub-id></citation>
      </ref>
      <ref id="CR81">
        <label>81.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dorf</surname>
              <given-names>ME</given-names>
            </name>
          </person-group>
          <article-title>Astrocytes express functional chemokine receptors</article-title>
          <source>J Neuroimmunol</source>
          <year>2000</year>
          <volume>111</volume>
          <fpage>109</fpage>
          <lpage>121</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dorf ME (2000) Astrocytes express functional chemokine receptors. J Neuroimmunol 111:109&#x2013;121 <pub-id pub-id-type="pmid">11063828</pub-id></citation>
      </ref>
      <ref id="CR82">
        <label>82.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ambrosini</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and glial cells: a complex network in the central nervous system</article-title>
          <source>Neurochem Res</source>
          <year>2004</year>
          <volume>29</volume>
          <fpage>1017</fpage>
          <lpage>1038</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ambrosini E (2004) Chemokines and glial cells: a complex network in the central nervous system. Neurochem Res 29:1017&#x2013;1038 <pub-id pub-id-type="pmid">15139300</pub-id></citation>
      </ref>
      <ref id="CR83">
        <label>83.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andjelkovic</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of CCR2 by human fetal astrocytes</article-title>
          <source>J Neurosci Res</source>
          <year>2002</year>
          <volume>70</volume>
          <fpage>219</fpage>
          <lpage>231</lpage>
        </citation>
        <citation citation-type="display-unstructured">Andjelkovic AV (2002) Functional expression of CCR2 by human fetal astrocytes. J Neurosci Res 70:219&#x2013;231 <pub-id pub-id-type="pmid">12271471</pub-id></citation>
      </ref>
      <ref id="CR84">
        <label>84.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Biber</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia</article-title>
          <source>Neuroscience</source>
          <year>2002</year>
          <volume>112</volume>
          <fpage>487</fpage>
          <lpage>497</lpage>
        </citation>
        <citation citation-type="display-unstructured">Biber K (2002) Functional expression of CXCR3 in cultured mouse and human astrocytes and microglia. Neuroscience 112:487&#x2013;497 <pub-id pub-id-type="pmid">12074892</pub-id></citation>
      </ref>
      <ref id="CR85">
        <label>85.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Klein</surname>
              <given-names>RS</given-names>
            </name>
          </person-group>
          <article-title>Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS</article-title>
          <source>J Immunol</source>
          <year>1999</year>
          <volume>163</volume>
          <fpage>1636</fpage>
          <lpage>1646</lpage>
        </citation>
        <citation citation-type="display-unstructured">Klein RS (1999) Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS. J Immunol 163:1636&#x2013;1646 <pub-id pub-id-type="pmid">10415069</pub-id></citation>
      </ref>
      <ref id="CR86">
        <label>86.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanabe</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>159</volume>
          <fpage>905</fpage>
          <lpage>911</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tanabe S (1997) Functional expression of the CXC-chemokine receptor-4/fusin on mouse microglial cells and astrocytes. J Immunol 159:905&#x2013;911 <pub-id pub-id-type="pmid">9218610</pub-id></citation>
      </ref>
      <ref id="CR87">
        <label>87.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bajetto</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway</article-title>
          <source>J Neurochem</source>
          <year>2001</year>
          <volume>77</volume>
          <fpage>1226</fpage>
          <lpage>1236</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bajetto A (2001) Stromal cell-derived factor-1alpha induces astrocyte proliferation through the activation of extracellular signal-regulated kinases 1/2 pathway. J Neurochem 77:1226&#x2013;1236 <pub-id pub-id-type="pmid">11389173</pub-id></citation>
      </ref>
      <ref id="CR88">
        <label>88.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boddeke</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Cultured rat microglia express functional beta-chemokine receptors</article-title>
          <source>J Neuroimmunol</source>
          <year>1999</year>
          <volume>98</volume>
          <fpage>176</fpage>
          <lpage>184</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boddeke EW (1999) Cultured rat microglia express functional beta-chemokine receptors. J Neuroimmunol 98:176&#x2013;184 <pub-id pub-id-type="pmid">10430051</pub-id></citation>
      </ref>
      <ref id="CR89">
        <label>89.</label>
        <citation citation-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Kettenmann</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <source>Neuroglia</source>
          <year>1995</year>
          <edition>2</edition>
          <publisher-loc>New York</publisher-loc>
          <publisher-name>Oxford University Press</publisher-name>
          <fpage>229</fpage>
          <lpage>239</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kettenmann H (1995) Neuroglia, 2nd edn. Oxford University Press, New York, pp 229&#x2013;239 </citation>
      </ref>
      <ref id="CR90">
        <label>90.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bezzi</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity</article-title>
          <source>Nat Neurosci</source>
          <year>2001</year>
          <volume>4</volume>
          <fpage>702</fpage>
          <lpage>710</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bezzi P (2001) CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity. Nat Neurosci 4:702&#x2013;710 <pub-id pub-id-type="pmid">11426226</pub-id></citation>
      </ref>
      <ref id="CR91">
        <label>91.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guyon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Complex effects of stromal cell-derived factor-1 alpha on melanin-concentrating hormone neuron excitability</article-title>
          <source>Eur J Neurosci</source>
          <year>2005</year>
          <volume>21</volume>
          <fpage>701</fpage>
          <lpage>710</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guyon A (2005) Complex effects of stromal cell-derived factor-1 alpha on melanin-concentrating hormone neuron excitability. Eur J Neurosci 21:701&#x2013;710 <pub-id pub-id-type="pmid">15733088</pub-id></citation>
      </ref>
      <ref id="CR92">
        <label>92.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guyon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms</article-title>
          <source>J Neurochem</source>
          <year>2006</year>
          <volume>96</volume>
          <fpage>1540</fpage>
          <lpage>1550</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guyon A (2006) Stromal cell-derived factor-1alpha modulation of the excitability of rat substantia nigra dopaminergic neurones: presynaptic mechanisms. J Neurochem 96:1540&#x2013;1550 <pub-id pub-id-type="pmid">16476083</pub-id></citation>
      </ref>
      <ref id="CR93">
        <label>93.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ragozzino</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>127</volume>
          <fpage>30</fpage>
          <lpage>36</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ragozzino D (2002) Stimulation of chemokine CXC receptor 4 induces synaptic depression of evoked parallel fibers inputs onto Purkinje neurons in mouse cerebellum. J Neuroimmunol 127:30&#x2013;36 <pub-id pub-id-type="pmid">12044972</pub-id></citation>
      </ref>
      <ref id="CR94">
        <label>94.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eng</surname>
              <given-names>LF</given-names>
            </name>
          </person-group>
          <article-title>GFAP and astrogliosis</article-title>
          <source>Brain Pathol</source>
          <year>1994</year>
          <volume>4</volume>
          <fpage>229</fpage>
          <lpage>237</lpage>
        </citation>
        <citation citation-type="display-unstructured">Eng LF (1994) GFAP and astrogliosis. Brain Pathol 4:229&#x2013;237 <pub-id pub-id-type="pmid">7952264</pub-id></citation>
      </ref>
      <ref id="CR95">
        <label>95.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Goldberg</surname>
              <given-names>SH</given-names>
            </name>
          </person-group>
          <article-title>CXCR3 expression in human central nervous system diseases</article-title>
          <source>Neuropathol Appl Neurobiol</source>
          <year>2001</year>
          <volume>27</volume>
          <fpage>127</fpage>
          <lpage>138</lpage>
        </citation>
        <citation citation-type="display-unstructured">Goldberg SH (2001) CXCR3 expression in human central nervous system diseases. Neuropathol Appl Neurobiol 27:127&#x2013;138 <pub-id pub-id-type="pmid">11437993</pub-id></citation>
      </ref>
      <ref id="CR96">
        <label>96.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue</article-title>
          <source>J Neuroimmunol</source>
          <year>2000</year>
          <volume>108</volume>
          <fpage>192</fpage>
          <lpage>200</lpage>
        </citation>
        <citation citation-type="display-unstructured">Simpson J (2000) Expression of the beta-chemokine receptors CCR2, CCR3 and CCR5 in multiple sclerosis central nervous system tissue. J Neuroimmunol 108:192&#x2013;200 <pub-id pub-id-type="pmid">10900353</pub-id></citation>
      </ref>
      <ref id="CR97">
        <label>97.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tanuma</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis</article-title>
          <source>Acta Neuropathol (Berl)</source>
          <year>2006</year>
          <volume>112</volume>
          <fpage>195</fpage>
          <lpage>204</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tanuma N (2006) Chemokine expression by astrocytes plays a role in microglia/macrophage activation and subsequent neurodegeneration in secondary progressive multiple sclerosis. Acta Neuropathol (Berl) 112:195&#x2013;204 <pub-id pub-id-type="pmid">16733654</pub-id></citation>
      </ref>
      <ref id="CR98">
        <label>98.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Flynn</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Regulation of chemokine receptor expression in human microglia and astrocytes</article-title>
          <source>J Neuroimmunol</source>
          <year>2003</year>
          <volume>136</volume>
          <fpage>84</fpage>
          <lpage>93</lpage>
        </citation>
        <citation citation-type="display-unstructured">Flynn G (2003) Regulation of chemokine receptor expression in human microglia and astrocytes. J Neuroimmunol 136:84&#x2013;93 <pub-id pub-id-type="pmid">12620646</pub-id></citation>
      </ref>
      <ref id="CR99">
        <label>99.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rezaie</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS</article-title>
          <source>Glia</source>
          <year>2002</year>
          <volume>37</volume>
          <fpage>64</fpage>
          <lpage>75</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rezaie P (2002) Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS. Glia 37:64&#x2013;75 <pub-id pub-id-type="pmid">11746784</pub-id></citation>
      </ref>
      <ref id="CR100">
        <label>100.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes</article-title>
          <source>J Clin Invest</source>
          <year>2001</year>
          <volume>108</volume>
          <fpage>425</fpage>
          <lpage>435</lpage>
        </citation>
        <citation citation-type="display-unstructured">Han Y (2001) TNF-alpha mediates SDF-1 alpha-induced NF-kappa B activation and cytotoxic effects in primary astrocytes. J Clin Invest 108:425&#x2013;435 <pub-id pub-id-type="pmid">11489936</pub-id></citation>
      </ref>
      <ref id="CR101">
        <label>101.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Han</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes</article-title>
          <source>Brain Res</source>
          <year>2001</year>
          <volume>888</volume>
          <fpage>1</fpage>
          <lpage>10</lpage>
        </citation>
        <citation citation-type="display-unstructured">Han Y (2001) TNF-alpha down-regulates CXCR4 expression in primary murine astrocytes. Brain Res 888:1&#x2013;10 <pub-id pub-id-type="pmid">11146046</pub-id></citation>
      </ref>
      <ref id="CR102">
        <label>102.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lazarini</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes</article-title>
          <source>Eur J Neurosci</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>117</fpage>
          <lpage>125</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lazarini F (2000) Differential signalling of the chemokine receptor CXCR4 by stromal cell-derived factor 1 and the HIV glycoprotein in rat neurons and astrocytes. Eur J Neurosci 12:117&#x2013;125 <pub-id pub-id-type="pmid">10651866</pub-id></citation>
      </ref>
      <ref id="CR103">
        <label>103.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heesen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor</article-title>
          <source>J Neurosci Res</source>
          <year>1996</year>
          <volume>45</volume>
          <fpage>382</fpage>
          <lpage>391</lpage>
        </citation>
        <citation citation-type="display-unstructured">Heesen M (1996) Mouse astrocytes respond to the chemokines MCP-1 and KC, but reverse transcriptase-polymerase chain reaction does not detect mRNA for the KC or new MCP-1 receptor. J Neurosci Res 45:382&#x2013;391 <pub-id pub-id-type="pmid">8872898</pub-id></citation>
      </ref>
      <ref id="CR104">
        <label>104.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Odemis</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation</article-title>
          <source>J Biol Chem</source>
          <year>2002</year>
          <volume>277</volume>
          <fpage>39801</fpage>
          <lpage>39808</lpage>
        </citation>
        <citation citation-type="display-unstructured">Odemis V (2002) Interleukin-6 and cAMP induce stromal cell-derived factor-1 chemotaxis in astroglia by up-regulating CXCR4 cell surface expression. Implications for brain inflammation. J Biol Chem 277:39801&#x2013;39808 <pub-id pub-id-type="pmid">12171912</pub-id></citation>
      </ref>
      <ref id="CR105">
        <label>105.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Davalos</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>ATP mediates rapid microglial response to local brain injury in vivo</article-title>
          <source>Nat Neurosci</source>
          <year>2005</year>
          <volume>8</volume>
          <fpage>752</fpage>
          <lpage>758</lpage>
        </citation>
        <citation citation-type="display-unstructured">Davalos D (2005) ATP mediates rapid microglial response to local brain injury in vivo. Nat Neurosci 8:752&#x2013;758 <pub-id pub-id-type="pmid">15895084</pub-id></citation>
      </ref>
      <ref id="CR106">
        <label>106.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nimmerjahn</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo</article-title>
          <source>Science</source>
          <year>2005</year>
          <volume>308</volume>
          <fpage>1314</fpage>
          <lpage>1318</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nimmerjahn A (2005) Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science 308:1314&#x2013;1318 <pub-id pub-id-type="pmid">15831717</pub-id></citation>
      </ref>
      <ref id="CR107">
        <label>107.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Town</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>The microglial &#x201C;activation&#x201D; continuum: from innate to adaptive responses</article-title>
          <source>J Neuroinflammation</source>
          <year>2005</year>
          <volume>2</volume>
          <fpage>24</fpage>
        </citation>
        <citation citation-type="display-unstructured">Town T (2005) The microglial &#x201C;activation&#x201D; continuum: from innate to adaptive responses. J Neuroinflammation 2:24 <pub-id pub-id-type="pmid">16259628</pub-id></citation>
      </ref>
      <ref id="CR108">
        <label>108.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kim</surname>
              <given-names>SU</given-names>
            </name>
          </person-group>
          <article-title>Microglia in health and disease</article-title>
          <source>J Neurosci Res</source>
          <year>2005</year>
          <volume>81</volume>
          <fpage>302</fpage>
          <lpage>313</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kim SU (2005) Microglia in health and disease. J Neurosci Res 81:302&#x2013;313 <pub-id pub-id-type="pmid">15954124</pub-id></citation>
      </ref>
      <ref id="CR109">
        <label>109.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kreutzberg</surname>
              <given-names>GW</given-names>
            </name>
          </person-group>
          <article-title>Microglia: a sensor for pathological events in the CNS</article-title>
          <source>Trends Neurosci</source>
          <year>1996</year>
          <volume>19</volume>
          <fpage>312</fpage>
          <lpage>318</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kreutzberg GW (1996) Microglia: a sensor for pathological events in the CNS. Trends Neurosci 19:312&#x2013;318 <pub-id pub-id-type="pmid">8843599</pub-id></citation>
      </ref>
      <ref id="CR110">
        <label>110.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Raivich</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function</article-title>
          <source>Brain Res Brain Res Rev</source>
          <year>1999</year>
          <volume>30</volume>
          <fpage>77</fpage>
          <lpage>105</lpage>
        </citation>
        <citation citation-type="display-unstructured">Raivich G (1999) Neuroglial activation repertoire in the injured brain: graded response, molecular mechanisms and cues to physiological function. Brain Res Brain Res Rev 30:77&#x2013;105 <pub-id pub-id-type="pmid">10407127</pub-id></citation>
      </ref>
      <ref id="CR111">
        <label>111.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Streit</surname>
              <given-names>WJ</given-names>
            </name>
          </person-group>
          <article-title>Reactive microgliosis</article-title>
          <source>Prog Neurobiol</source>
          <year>1999</year>
          <volume>57</volume>
          <fpage>563</fpage>
          <lpage>581</lpage>
        </citation>
        <citation citation-type="display-unstructured">Streit WJ (1999) Reactive microgliosis. Prog Neurobiol 57:563&#x2013;581 <pub-id pub-id-type="pmid">10221782</pub-id></citation>
      </ref>
      <ref id="CR112">
        <label>112.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cross</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro</article-title>
          <source>J Neurosci Res</source>
          <year>1999</year>
          <volume>55</volume>
          <fpage>17</fpage>
          <lpage>23</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cross AK (1999) Chemokines induce migration and changes in actin polymerization in adult rat brain microglia and a human fetal microglial cell line in vitro. J Neurosci Res 55:17&#x2013;23 <pub-id pub-id-type="pmid">9890430</pub-id></citation>
      </ref>
      <ref id="CR113">
        <label>113.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hulshof</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2003</year>
          <volume>62</volume>
          <fpage>899</fpage>
          <lpage>907</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hulshof S (2003) CX3CL1 and CX3CR1 expression in human brain tissue: noninflammatory control versus multiple sclerosis. J Neuropathol Exp Neurol 62:899&#x2013;907 <pub-id pub-id-type="pmid">14533779</pub-id></citation>
      </ref>
      <ref id="CR114">
        <label>114.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kuipers</surname>
              <given-names>HF</given-names>
            </name>
          </person-group>
          <article-title>Simvastatin affects cell motility and actin cytoskeleton distribution of microglia</article-title>
          <source>Glia</source>
          <year>2006</year>
          <volume>53</volume>
          <fpage>115</fpage>
          <lpage>123</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kuipers HF (2006) Simvastatin affects cell motility and actin cytoskeleton distribution of microglia. Glia 53:115&#x2013;123 <pub-id pub-id-type="pmid">16206159</pub-id></citation>
      </ref>
      <ref id="CR115">
        <label>115.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Rappert</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl-current and chemotaxis in murine microglia</article-title>
          <source>J Immunol</source>
          <year>2002</year>
          <volume>168</volume>
          <fpage>3221</fpage>
          <lpage>3226</lpage>
        </citation>
        <citation citation-type="display-unstructured">Rappert A (2002) Secondary lymphoid tissue chemokine (CCL21) activates CXCR3 to trigger a Cl-current and chemotaxis in murine microglia. J Immunol 168:3221&#x2013;3226 <pub-id pub-id-type="pmid">11907075</pub-id></citation>
      </ref>
      <ref id="CR116">
        <label>116.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jung</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion</article-title>
          <source>Mol Cell Biol</source>
          <year>2000</year>
          <volume>20</volume>
          <fpage>4106</fpage>
          <lpage>4114</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jung S (2000) Analysis of fractalkine receptor CX(3)CR1 function by targeted deletion and green fluorescent protein reporter gene insertion. Mol Cell Biol 20:4106&#x2013;4114 <pub-id pub-id-type="pmid">10805752</pub-id></citation>
      </ref>
      <ref id="CR117">
        <label>117.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Soriano</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>Mice deficient in fractalkine are less susceptible to cerebral ischemia&#x2013;reperfusion injury</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>125</volume>
          <fpage>59</fpage>
          <lpage>65</lpage>
        </citation>
        <citation citation-type="display-unstructured">Soriano SG (2002) Mice deficient in fractalkine are less susceptible to cerebral ischemia&#x2013;reperfusion injury. J Neuroimmunol 125:59&#x2013;65 <pub-id pub-id-type="pmid">11960641</pub-id></citation>
      </ref>
      <ref id="CR118">
        <label>118.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zujovic</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation</article-title>
          <source>Glia</source>
          <year>2000</year>
          <volume>29</volume>
          <fpage>305</fpage>
          <lpage>315</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zujovic V (2000) Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia 29:305&#x2013;315 <pub-id pub-id-type="pmid">10652441</pub-id></citation>
      </ref>
      <ref id="CR119">
        <label>119.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boehme</surname>
              <given-names>SA</given-names>
            </name>
          </person-group>
          <article-title>The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia</article-title>
          <source>J Immunol</source>
          <year>2000</year>
          <volume>165</volume>
          <fpage>397</fpage>
          <lpage>403</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boehme SA (2000) The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia. J Immunol 165:397&#x2013;403 <pub-id pub-id-type="pmid">10861077</pub-id></citation>
      </ref>
      <ref id="CR120">
        <label>120.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bechmann</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>Involvement of non-neuronal cells in entorhinal-hippocampal reorganization following lesions</article-title>
          <source>Ann N Y Acad Sci</source>
          <year>2000</year>
          <volume>911</volume>
          <fpage>192</fpage>
          <lpage>206</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bechmann I (2000) Involvement of non-neuronal cells in entorhinal-hippocampal reorganization following lesions. Ann N Y Acad Sci 911:192&#x2013;206 <pub-id pub-id-type="pmid">10911875</pub-id></citation>
      </ref>
      <ref id="CR121">
        <label>121.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banati</surname>
              <given-names>RB</given-names>
            </name>
          </person-group>
          <article-title>Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation?</article-title>
          <source>J Physiol Paris</source>
          <year>2002</year>
          <volume>96</volume>
          <fpage>289</fpage>
          <lpage>299</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banati RB (2002) Brain plasticity and microglia: is transsynaptic glial activation in the thalamus after limb denervation linked to cortical plasticity and central sensitisation? J Physiol Paris 96:289&#x2013;299 <pub-id pub-id-type="pmid">12445908</pub-id></citation>
      </ref>
      <ref id="CR122">
        <label>122.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gerard</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Chemokines: back to the future?</article-title>
          <source>Nat Cell Biol</source>
          <year>2001</year>
          <volume>3</volume>
          <fpage>E53</fpage>
          <lpage>E54</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gerard C (2001) Chemokines: back to the future? Nat Cell Biol 3:E53&#x2013;E54 <pub-id pub-id-type="pmid">11175764</pub-id></citation>
      </ref>
      <ref id="CR123">
        <label>123.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muessel</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules</article-title>
          <source>Brain Res Mol Brain Res</source>
          <year>2002</year>
          <volume>103</volume>
          <fpage>12</fpage>
          <lpage>27</lpage>
        </citation>
        <citation citation-type="display-unstructured">Muessel MJ (2002) Ablation of the chemokine monocyte chemoattractant protein-1 delays retrograde neuronal degeneration, attenuates microglial activation, and alters expression of cell death molecules. Brain Res Mol Brain Res 103:12&#x2013;27 <pub-id pub-id-type="pmid">12106688</pub-id></citation>
      </ref>
      <ref id="CR124">
        <label>124.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Muessel</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cortical injury</article-title>
          <source>Brain Res</source>
          <year>2000</year>
          <volume>870</volume>
          <fpage>211</fpage>
          <lpage>221</lpage>
        </citation>
        <citation citation-type="display-unstructured">Muessel MJ (2000) Early and specific expression of monocyte chemoattractant protein-1 in the thalamus induced by cortical injury. Brain Res 870:211&#x2013;221 <pub-id pub-id-type="pmid">10869521</pub-id></citation>
      </ref>
      <ref id="CR125">
        <label>125.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Li</surname>
              <given-names>H</given-names>
            </name>
          </person-group>
          <article-title>Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia</article-title>
          <source>J Immunol</source>
          <year>2006</year>
          <volume>177</volume>
          <fpage>3644</fpage>
          <lpage>3656</lpage>
        </citation>
        <citation citation-type="display-unstructured">Li H (2006) Different neurotropic pathogens elicit neurotoxic CCR9- or neurosupportive CXCR3-expressing microglia. J Immunol 177:3644&#x2013;3656 <pub-id pub-id-type="pmid">16951324</pub-id></citation>
      </ref>
      <ref id="CR126">
        <label>126.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lieberam</surname>
              <given-names>I</given-names>
            </name>
          </person-group>
          <article-title>A Cxcl12&#x2013;CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons</article-title>
          <source>Neuron</source>
          <year>2005</year>
          <volume>47</volume>
          <fpage>667</fpage>
          <lpage>679</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lieberam I (2005) A Cxcl12&#x2013;CXCR4 chemokine signaling pathway defines the initial trajectory of mammalian motor axons. Neuron 47:667&#x2013;679 <pub-id pub-id-type="pmid">16129397</pub-id></citation>
      </ref>
      <ref id="CR127">
        <label>127.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Pujol</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons</article-title>
          <source>J Cell Sci</source>
          <year>2005</year>
          <volume>118</volume>
          <fpage>1071</fpage>
          <lpage>1080</lpage>
        </citation>
        <citation citation-type="display-unstructured">Pujol F (2005) The chemokine SDF-1 differentially regulates axonal elongation and branching in hippocampal neurons. J Cell Sci 118:1071&#x2013;1080 <pub-id pub-id-type="pmid">15731012</pub-id></citation>
      </ref>
      <ref id="CR128">
        <label>128.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Limatola</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>6197</fpage>
          <lpage>6201</lpage>
        </citation>
        <citation citation-type="display-unstructured">Limatola C (2000) The chemokine growth-related gene product beta protects rat cerebellar granule cells from apoptotic cell death through alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionate receptors. Proc Natl Acad Sci U S A 97:6197&#x2013;6201 <pub-id pub-id-type="pmid">10811878</pub-id></citation>
      </ref>
      <ref id="CR129">
        <label>129.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>Q</given-names>
            </name>
          </person-group>
          <article-title><italic>N</italic>-methyl-<sc>d</sc>-aspartate attenuates CXCR2-mediated neuroprotection through enhancing the receptor phosphorylation and blocking the receptor recycling</article-title>
          <source>Mol Pharmacol</source>
          <year>2005</year>
          <volume>68</volume>
          <fpage>528</fpage>
          <lpage>537</lpage>
        </citation>
        <citation citation-type="display-unstructured">Luo Q (2005) N-methyl-d-aspartate attenuates CXCR2-mediated neuroprotection through enhancing the receptor phosphorylation and blocking the receptor recycling. Mol Pharmacol 68:528&#x2013;537 <pub-id pub-id-type="pmid">15914698</pub-id></citation>
      </ref>
      <ref id="CR130">
        <label>130.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Watson</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways</article-title>
          <source>Mol Pharmacol</source>
          <year>2005</year>
          <volume>67</volume>
          <fpage>757</fpage>
          <lpage>765</lpage>
        </citation>
        <citation citation-type="display-unstructured">Watson K (2005) Macrophage inflammatory protein 2 inhibits beta-amyloid peptide (1-42)-mediated hippocampal neuronal apoptosis through activation of mitogen-activated protein kinase and phosphatidylinositol 3-kinase signaling pathways. Mol Pharmacol 67:757&#x2013;765 <pub-id pub-id-type="pmid">15608143</pub-id></citation>
      </ref>
      <ref id="CR131">
        <label>131.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Giovannelli</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum</article-title>
          <source>J Neuroimmunol</source>
          <year>1998</year>
          <volume>92</volume>
          <fpage>122</fpage>
          <lpage>132</lpage>
        </citation>
        <citation citation-type="display-unstructured">Giovannelli A (1998) CXC chemokines interleukin-8 (IL-8) and growth-related gene product alpha (GROalpha) modulate Purkinje neuron activity in mouse cerebellum. J Neuroimmunol 92:122&#x2013;132 <pub-id pub-id-type="pmid">9916887</pub-id></citation>
      </ref>
      <ref id="CR132">
        <label>132.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puma</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs</article-title>
          <source>J Neurochem</source>
          <year>2001</year>
          <volume>78</volume>
          <fpage>960</fpage>
          <lpage>971</lpage>
        </citation>
        <citation citation-type="display-unstructured">Puma C (2001) The chemokine interleukin-8 acutely reduces Ca(2+) currents in identified cholinergic septal neurons expressing CXCR1 and CXCR2 receptor mRNAs. J Neurochem 78:960&#x2013;971 <pub-id pub-id-type="pmid">11553670</pub-id></citation>
      </ref>
      <ref id="CR133">
        <label>133.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Limatola</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum</article-title>
          <source>Eur J Neurosci</source>
          <year>2000</year>
          <volume>12</volume>
          <fpage>2497</fpage>
          <lpage>2504</lpage>
        </citation>
        <citation citation-type="display-unstructured">Limatola C (2000) SDF-1alpha-mediated modulation of synaptic transmission in rat cerebellum. Eur J Neurosci 12:2497&#x2013;2504 <pub-id pub-id-type="pmid">10947825</pub-id></citation>
      </ref>
      <ref id="CR134">
        <label>134.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Dong</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices</article-title>
          <source>J Neurosci Res</source>
          <year>2006</year>
          <volume>83</volume>
          <fpage>489</fpage>
          <lpage>496</lpage>
        </citation>
        <citation citation-type="display-unstructured">Dong J (2006) Human immunodeficiency virus type 1 gp120 inhibits long-term potentiation via chemokine receptor CXCR4 in rat hippocampal slices. J Neurosci Res 83:489&#x2013;496 <pub-id pub-id-type="pmid">16400660</pub-id></citation>
      </ref>
      <ref id="CR135">
        <label>135.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaul</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Pathways to neuronal injury and apoptosis in HIV-associated dementia</article-title>
          <source>Nature</source>
          <year>2001</year>
          <volume>410</volume>
          <fpage>988</fpage>
          <lpage>994</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kaul M (2001) Pathways to neuronal injury and apoptosis in HIV-associated dementia. Nature 410:988&#x2013;994 <pub-id pub-id-type="pmid">11309629</pub-id></citation>
      </ref>
      <ref id="CR136">
        <label>136.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masliah</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Selective neuronal vulnerability in HIV encephalitis</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>1992</year>
          <volume>51</volume>
          <fpage>585</fpage>
          <lpage>593</lpage>
        </citation>
        <citation citation-type="display-unstructured">Masliah E (1992) Selective neuronal vulnerability in HIV encephalitis. J Neuropathol Exp Neurol 51:585&#x2013;593 <pub-id pub-id-type="pmid">1484289</pub-id></citation>
      </ref>
      <ref id="CR137">
        <label>137.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Masliah</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer&#x2019;s disease</article-title>
          <source>Lab Invest</source>
          <year>1997</year>
          <volume>77</volume>
          <fpage>197</fpage>
          <lpage>209</lpage>
        </citation>
        <citation citation-type="display-unstructured">Masliah E (1997) Role of amyloid precursor protein in the mechanisms of neurodegeneration in Alzheimer&#x2019;s disease. Lab Invest 77:197&#x2013;209 <pub-id pub-id-type="pmid">9314943</pub-id></citation>
      </ref>
      <ref id="CR138">
        <label>138.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Deiva</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine reduces <italic>N</italic>-methyl-<italic>d</italic>-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation</article-title>
          <source>Eur J Neurosci</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>3222</fpage>
          <lpage>3232</lpage>
        </citation>
        <citation citation-type="display-unstructured">Deiva K (2004) Fractalkine reduces N-methyl-d-aspartate-induced calcium flux and apoptosis in human neurons through extracellular signal-regulated kinase activation. Eur J Neurosci 20:3222&#x2013;3232 <pub-id pub-id-type="pmid">15610155</pub-id></citation>
      </ref>
      <ref id="CR139">
        <label>139.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meucci</surname>
              <given-names>O</given-names>
            </name>
          </person-group>
          <article-title>Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2000</year>
          <volume>97</volume>
          <fpage>8075</fpage>
          <lpage>8080</lpage>
        </citation>
        <citation citation-type="display-unstructured">Meucci O (2000) Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival. Proc Natl Acad Sci U S A 97:8075&#x2013;8080 <pub-id pub-id-type="pmid">10869418</pub-id></citation>
      </ref>
      <ref id="CR140">
        <label>140.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gillard</surname>
              <given-names>SE</given-names>
            </name>
          </person-group>
          <article-title>Expression of functional chemokine receptors by rat cerebellar neurons</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>124</volume>
          <fpage>16</fpage>
          <lpage>28</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gillard SE (2002) Expression of functional chemokine receptors by rat cerebellar neurons. J Neuroimmunol 124:16&#x2013;28 <pub-id pub-id-type="pmid">11958818</pub-id></citation>
      </ref>
      <ref id="CR141">
        <label>141.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bruno</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Neuroprotective activity of chemokines against <italic>N</italic>-methyl-<sc>d</sc>-aspartate or beta-amyloid-induced toxicity in culture</article-title>
          <source>Eur J Pharmacol</source>
          <year>2000</year>
          <volume>399</volume>
          <fpage>117</fpage>
          <lpage>121</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bruno V (2000) Neuroprotective activity of chemokines against N-methyl-d-aspartate or beta-amyloid-induced toxicity in culture. Eur J Pharmacol 399:117&#x2013;121 <pub-id pub-id-type="pmid">10884510</pub-id></citation>
      </ref>
      <ref id="CR142">
        <label>142.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eugenin</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis</article-title>
          <source>J Neurochem</source>
          <year>2003</year>
          <volume>85</volume>
          <fpage>1299</fpage>
          <lpage>1311</lpage>
        </citation>
        <citation citation-type="display-unstructured">Eugenin EA (2003) MCP-1 (CCL2) protects human neurons and astrocytes from NMDA or HIV-tat-induced apoptosis. J Neurochem 85:1299&#x2013;1311 <pub-id pub-id-type="pmid">12753088</pub-id></citation>
      </ref>
      <ref id="CR143">
        <label>143.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Catani</surname>
              <given-names>MV</given-names>
            </name>
          </person-group>
          <article-title>gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors</article-title>
          <source>J Neurochem</source>
          <year>2000</year>
          <volume>74</volume>
          <fpage>2373</fpage>
          <lpage>2379</lpage>
        </citation>
        <citation citation-type="display-unstructured">Catani MV (2000) gp120 induces cell death in human neuroblastoma cells through the CXCR4 and CCR5 chemokine receptors. J Neurochem 74:2373&#x2013;2379 <pub-id pub-id-type="pmid">10820198</pub-id></citation>
      </ref>
      <ref id="CR144">
        <label>144.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Brenneman</surname>
              <given-names>DE</given-names>
            </name>
          </person-group>
          <article-title>Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide</article-title>
          <source>Nature</source>
          <year>1988</year>
          <volume>335</volume>
          <fpage>639</fpage>
          <lpage>642</lpage>
        </citation>
        <citation citation-type="display-unstructured">Brenneman DE (1988) Neuronal cell killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature 335:639&#x2013;642 <pub-id pub-id-type="pmid">2845276</pub-id></citation>
      </ref>
      <ref id="CR145">
        <label>145.</label>
        <citation citation-type="other">Kaul M (2007) HIV-1 coreceptors CCR5 and CXCR4 both mediate neuronal cell death but CCR5 paradoxically can also contribute to protection. Cell Death Differ (in press)</citation>
      </ref>
      <ref id="CR146">
        <label>146.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hesselgesser</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4</article-title>
          <source>Curr Biol</source>
          <year>1998</year>
          <volume>8</volume>
          <fpage>595</fpage>
          <lpage>598</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hesselgesser J (1998) Neuronal apoptosis induced by HIV-1 gp120 and the chemokine SDF-1 alpha is mediated by the chemokine receptor CXCR4. Curr Biol 8:595&#x2013;598 <pub-id pub-id-type="pmid">9601645</pub-id></citation>
      </ref>
      <ref id="CR147">
        <label>147.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Bachis</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>The chemokine receptor CXCR4 and not the <italic>N</italic>-methyl-<sc>d</sc>-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells</article-title>
          <source>J Neurosci Res</source>
          <year>2004</year>
          <volume>75</volume>
          <fpage>75</fpage>
          <lpage>82</lpage>
        </citation>
        <citation citation-type="display-unstructured">Bachis A (2004) The chemokine receptor CXCR4 and not the N-methyl-d-aspartate receptor mediates gp120 neurotoxicity in cerebellar granule cells. J Neurosci Res 75:75&#x2013;82 <pub-id pub-id-type="pmid">14689450</pub-id></citation>
      </ref>
      <ref id="CR148">
        <label>148.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kaul</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1999</year>
          <volume>96</volume>
          <fpage>8212</fpage>
          <lpage>8216</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kaul M (1999) Chemokines and activated macrophages in HIV gp120-induced neuronal apoptosis. Proc Natl Acad Sci USA 96:8212&#x2013;8216 <pub-id pub-id-type="pmid">10393974</pub-id></citation>
      </ref>
      <ref id="CR149">
        <label>149.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Geeraerts</surname>
              <given-names>T</given-names>
            </name>
          </person-group>
          <article-title>Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells</article-title>
          <source>Neurosci Lett</source>
          <year>2006</year>
          <volume>399</volume>
          <fpage>115</fpage>
          <lpage>120</lpage>
        </citation>
        <citation citation-type="display-unstructured">Geeraerts T (2006) Effects of SDF-1alpha and gp120IIIB on apoptotic pathways in SK-N-SH neuroblastoma cells. Neurosci Lett 399:115&#x2013;120 <pub-id pub-id-type="pmid">16481105</pub-id></citation>
      </ref>
      <ref id="CR150">
        <label>150.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>K</given-names>
            </name>
          </person-group>
          <article-title>HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration</article-title>
          <source>Nat Neurosci</source>
          <year>2003</year>
          <volume>6</volume>
          <fpage>1064</fpage>
          <lpage>1071</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zhang K (2003) HIV-induced metalloproteinase processing of the chemokine stromal cell derived factor-1 causes neurodegeneration. Nat Neurosci 6:1064&#x2013;1071 <pub-id pub-id-type="pmid">14502291</pub-id></citation>
      </ref>
      <ref id="CR151">
        <label>151.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ransohoff</surname>
              <given-names>RM</given-names>
            </name>
          </person-group>
          <article-title>Snip&#x2013;snip, kill&#x2013;kill: truncated SDF-1 and HIV-associated neurodegeneration</article-title>
          <source>Nat Neurosci</source>
          <year>2003</year>
          <volume>6</volume>
          <fpage>1009</fpage>
          <lpage>1011</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ransohoff RM (2003) Snip&#x2013;snip, kill&#x2013;kill: truncated SDF-1 and HIV-associated neurodegeneration. Nat Neurosci 6:1009&#x2013;1011 <pub-id pub-id-type="pmid">14513034</pub-id></citation>
      </ref>
      <ref id="CR152">
        <label>152.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sui</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>CXCL10-induced cell death in neurons: role of calcium dysregulation</article-title>
          <source>Eur J Neurosci</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>957</fpage>
          <lpage>964</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sui Y (2006) CXCL10-induced cell death in neurons: role of calcium dysregulation. Eur J Neurosci 23:957&#x2013;964 <pub-id pub-id-type="pmid">16519660</pub-id></citation>
      </ref>
      <ref id="CR153">
        <label>153.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Marle</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10</article-title>
          <source>Virology</source>
          <year>2004</year>
          <volume>329</volume>
          <fpage>302</fpage>
          <lpage>318</lpage>
        </citation>
        <citation citation-type="display-unstructured">van Marle G (2004) Human immunodeficiency virus type 1 Nef protein mediates neural cell death: a neurotoxic role for IP-10. Virology 329:302&#x2013;318 <pub-id pub-id-type="pmid">15518810</pub-id></citation>
      </ref>
      <ref id="CR154">
        <label>154.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kasyanov</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 gp120 enhances giant depolarizing potentials via chemokine receptor CXCR4 in neonatal rat hippocampus</article-title>
          <source>Eur J Neurosci</source>
          <year>2006</year>
          <volume>23</volume>
          <fpage>1120</fpage>
          <lpage>1128</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kasyanov A (2006) HIV-1 gp120 enhances giant depolarizing potentials via chemokine receptor CXCR4 in neonatal rat hippocampus. Eur J Neurosci 23:1120&#x2013;1128 <pub-id pub-id-type="pmid">16553776</pub-id></citation>
      </ref>
      <ref id="CR155">
        <label>155.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Cho</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Chemokine receptors and neural function</article-title>
          <source>J Neurovirol</source>
          <year>2002</year>
          <volume>8</volume>
          <fpage>573</fpage>
          <lpage>584</lpage>
        </citation>
        <citation citation-type="display-unstructured">Cho C (2002) Chemokine receptors and neural function. J Neurovirol 8:573&#x2013;584 <pub-id pub-id-type="pmid">12476351</pub-id></citation>
      </ref>
      <ref id="CR156">
        <label>156.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Ragozzino</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Modulation of the neurotransmitter release in rat cerebellar neurons by GRO beta</article-title>
          <source>Neuroreport</source>
          <year>1998</year>
          <volume>9</volume>
          <fpage>3601</fpage>
          <lpage>3606</lpage>
        </citation>
        <citation citation-type="display-unstructured">Ragozzino D (1998) Modulation of the neurotransmitter release in rat cerebellar neurons by GRO beta. Neuroreport 9:3601&#x2013;3606 <pub-id pub-id-type="pmid">9858367</pub-id></citation>
      </ref>
      <ref id="CR157">
        <label>157.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Electrophysiological analysis of neuronal chemokine receptors</article-title>
          <source>Methods</source>
          <year>2003</year>
          <volume>29</volume>
          <fpage>335</fpage>
          <lpage>344</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oh SB (2003) Electrophysiological analysis of neuronal chemokine receptors. Methods 29:335&#x2013;344 <pub-id pub-id-type="pmid">12725800</pub-id></citation>
      </ref>
      <ref id="CR158">
        <label>158.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons</article-title>
          <source>J Neurosci</source>
          <year>2001</year>
          <volume>21</volume>
          <fpage>5027</fpage>
          <lpage>5035</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oh SB (2001) Chemokines and glycoprotein120 produce pain hypersensitivity by directly exciting primary nociceptive neurons. J Neurosci 21:5027&#x2013;5035 <pub-id pub-id-type="pmid">11438578</pub-id></citation>
      </ref>
      <ref id="CR159">
        <label>159.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Oh</surname>
              <given-names>SB</given-names>
            </name>
          </person-group>
          <article-title>Regulation of calcium currents by chemokines and their receptors</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>123</volume>
          <fpage>66</fpage>
          <lpage>75</lpage>
        </citation>
        <citation citation-type="display-unstructured">Oh SB (2002) Regulation of calcium currents by chemokines and their receptors. J Neuroimmunol 123:66&#x2013;75 <pub-id pub-id-type="pmid">11880151</pub-id></citation>
      </ref>
      <ref id="CR160">
        <label>160.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tran</surname>
              <given-names>PB</given-names>
            </name>
          </person-group>
          <article-title>Chemokine receptors in the brain: a developing story</article-title>
          <source>J Comp Neurol</source>
          <year>2003</year>
          <volume>457</volume>
          <fpage>1</fpage>
          <lpage>6</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tran PB (2003) Chemokine receptors in the brain: a developing story. J Comp Neurol 457:1&#x2013;6 <pub-id pub-id-type="pmid">12541320</pub-id></citation>
      </ref>
      <ref id="CR161">
        <label>161.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gosselin</surname>
              <given-names>RD</given-names>
            </name>
          </person-group>
          <article-title>Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones</article-title>
          <source>J Neurochem</source>
          <year>2005</year>
          <volume>95</volume>
          <fpage>1023</fpage>
          <lpage>1034</lpage>
        </citation>
        <citation citation-type="display-unstructured">Gosselin RD (2005) Constitutive expression of CCR2 chemokine receptor and inhibition by MCP-1/CCL2 of GABA-induced currents in spinal cord neurones. J Neurochem 95:1023&#x2013;1034 <pub-id pub-id-type="pmid">16150057</pub-id></citation>
      </ref>
      <ref id="CR162">
        <label>162.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guyon</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Stromal cell-derived factor-1alpha directly modulates voltage-dependent currents of the action potential in mammalian neuronal cells</article-title>
          <source>J Neurochem</source>
          <year>2005</year>
          <volume>93</volume>
          <fpage>963</fpage>
          <lpage>973</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guyon A (2005) Stromal cell-derived factor-1alpha directly modulates voltage-dependent currents of the action potential in mammalian neuronal cells. J Neurochem 93:963&#x2013;973 <pub-id pub-id-type="pmid">15857399</pub-id></citation>
      </ref>
      <ref id="CR163">
        <label>163.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Nelson</surname>
              <given-names>TE</given-names>
            </name>
          </person-group>
          <article-title>The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons</article-title>
          <source>J Neuroimmunol</source>
          <year>2004</year>
          <volume>156</volume>
          <fpage>74</fpage>
          <lpage>87</lpage>
        </citation>
        <citation citation-type="display-unstructured">Nelson TE (2004) The chemokine CXCL10 modulates excitatory activity and intracellular calcium signaling in cultured hippocampal neurons. J Neuroimmunol 156:74&#x2013;87 <pub-id pub-id-type="pmid">15465598</pub-id></citation>
      </ref>
      <ref id="CR164">
        <label>164.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gassen</surname>
              <given-names>KL</given-names>
            </name>
          </person-group>
          <article-title>The chemokine CCL2 modulates Ca2+ dynamics and electrophysiological properties of cultured cerebellar Purkinje neurons</article-title>
          <source>Eur J Neurosci</source>
          <year>2005</year>
          <volume>21</volume>
          <fpage>2949</fpage>
          <lpage>2957</lpage>
        </citation>
        <citation citation-type="display-unstructured">van Gassen KL (2005) The chemokine CCL2 modulates Ca2+ dynamics and electrophysiological properties of cultured cerebellar Purkinje neurons. Eur J Neurosci 21:2949&#x2013;2957 <pub-id pub-id-type="pmid">15978006</pub-id></citation>
      </ref>
      <ref id="CR165">
        <label>165.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Liu</surname>
              <given-names>Z</given-names>
            </name>
          </person-group>
          <article-title>Frequency modulation of synchronized Ca2+ spikes in cultured hippocampal networks through G-protein-coupled receptors</article-title>
          <source>J Neurosci</source>
          <year>2003</year>
          <volume>23</volume>
          <fpage>4156</fpage>
          <lpage>4163</lpage>
        </citation>
        <citation citation-type="display-unstructured">Liu Z (2003) Frequency modulation of synchronized Ca2+ spikes in cultured hippocampal networks through G-protein-coupled receptors. J Neurosci 23:4156&#x2013;4163 <pub-id pub-id-type="pmid">12764103</pub-id></citation>
      </ref>
      <ref id="CR166">
        <label>166.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vlkolinsky</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices</article-title>
          <source>J Neuroimmunol</source>
          <year>2004</year>
          <volume>150</volume>
          <fpage>37</fpage>
          <lpage>47</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vlkolinsky R (2004) Acute exposure to CXC chemokine ligand 10, but not its chronic astroglial production, alters synaptic plasticity in mouse hippocampal slices. J Neuroimmunol 150:37&#x2013;47 <pub-id pub-id-type="pmid">15081247</pub-id></citation>
      </ref>
      <ref id="CR167">
        <label>167.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Baudouin</surname>
              <given-names>SJ</given-names>
            </name>
          </person-group>
          <article-title>Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation</article-title>
          <source>Mol Cell Neurosci</source>
          <year>2006</year>
          <volume>33</volume>
          <issue>2</issue>
          <fpage>160</fpage>
          <lpage>169</lpage>
        </citation>
        <citation citation-type="display-unstructured">Baudouin SJ (2006) Dendrite-selective redistribution of the chemokine receptor CXCR4 following agonist stimulation. Mol Cell Neurosci 33(2):160&#x2013;169 <pub-id pub-id-type="pmid">16952464</pub-id></citation>
      </ref>
      <ref id="CR168">
        <label>168.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jo</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Upregulation of chemokine expression in the retinal vasculature in ischemia&#x2013;reperfusion injury</article-title>
          <source>Invest Ophthalmol Vis Sci</source>
          <year>2003</year>
          <volume>44</volume>
          <fpage>4054</fpage>
          <lpage>4060</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jo N (2003) Upregulation of chemokine expression in the retinal vasculature in ischemia&#x2013;reperfusion injury. Invest Ophthalmol Vis Sci 44:4054&#x2013;4060 <pub-id pub-id-type="pmid">12939328</pub-id></citation>
      </ref>
      <ref id="CR169">
        <label>169.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Puri</surname>
              <given-names>V</given-names>
            </name>
          </person-group>
          <article-title>Effects of oestrogen on trigeminal ganglia in culture: implications for hormonal effects on migraine</article-title>
          <source>Cephalalgia</source>
          <year>2006</year>
          <volume>26</volume>
          <fpage>33</fpage>
          <lpage>42</lpage>
        </citation>
        <citation citation-type="display-unstructured">Puri V (2006) Effects of oestrogen on trigeminal ganglia in culture: implications for hormonal effects on migraine. Cephalalgia 26:33&#x2013;42 <pub-id pub-id-type="pmid">16396664</pub-id></citation>
      </ref>
      <ref id="CR170">
        <label>170.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tong</surname>
              <given-names>N</given-names>
            </name>
          </person-group>
          <article-title>Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system</article-title>
          <source>J Immunol</source>
          <year>2000</year>
          <volume>164</volume>
          <fpage>1333</fpage>
          <lpage>1339</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tong N (2000) Neuronal fractalkine expression in HIV-1 encephalitis: roles for macrophage recruitment and neuroprotection in the central nervous system. J Immunol 164:1333&#x2013;1339 <pub-id pub-id-type="pmid">10640747</pub-id></citation>
      </ref>
      <ref id="CR171">
        <label>171.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lindia</surname>
              <given-names>JA</given-names>
            </name>
          </person-group>
          <article-title>Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain</article-title>
          <source>J Pain</source>
          <year>2005</year>
          <volume>6</volume>
          <fpage>434</fpage>
          <lpage>438</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lindia JA (2005) Induction of CX3CL1 expression in astrocytes and CX3CR1 in microglia in the spinal cord of a rat model of neuropathic pain. J Pain 6:434&#x2013;438 <pub-id pub-id-type="pmid">15993821</pub-id></citation>
      </ref>
      <ref id="CR172">
        <label>172.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Verge</surname>
              <given-names>GM</given-names>
            </name>
          </person-group>
          <article-title>Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions</article-title>
          <source>Eur J Neurosci</source>
          <year>2004</year>
          <volume>20</volume>
          <fpage>1150</fpage>
          <lpage>1160</lpage>
        </citation>
        <citation citation-type="display-unstructured">Verge GM (2004) Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions. Eur J Neurosci 20:1150&#x2013;1160 <pub-id pub-id-type="pmid">15341587</pub-id></citation>
      </ref>
      <ref id="CR173">
        <label>173.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>McManus</surname>
              <given-names>CM</given-names>
            </name>
          </person-group>
          <article-title>Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation</article-title>
          <source>Am J Pathol</source>
          <year>2000</year>
          <volume>156</volume>
          <fpage>1441</fpage>
          <lpage>1453</lpage>
        </citation>
        <citation citation-type="display-unstructured">McManus CM (2000) Chemokine and chemokine-receptor expression in human glial elements: induction by the HIV protein, Tat, and chemokine autoregulation. Am J Pathol 156:1441&#x2013;1453 <pub-id pub-id-type="pmid">10751368</pub-id></citation>
      </ref>
      <ref id="CR174">
        <label>174.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Andjelkovic</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Expression of binding sites for beta chemokines on human astrocytes</article-title>
          <source>Glia</source>
          <year>1999</year>
          <volume>28</volume>
          <fpage>225</fpage>
          <lpage>235</lpage>
        </citation>
        <citation citation-type="display-unstructured">Andjelkovic AV (1999) Expression of binding sites for beta chemokines on human astrocytes. Glia 28:225&#x2013;235 <pub-id pub-id-type="pmid">10559781</pub-id></citation>
      </ref>
      <ref id="CR175">
        <label>175.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Croitoru-Lamoury</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation</article-title>
          <source>Glia</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>354</fpage>
          <lpage>370</lpage>
        </citation>
        <citation citation-type="display-unstructured">Croitoru-Lamoury J (2003) Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF alpha and IFN gamma in CXCR4 and CCR5 modulation. Glia 41:354&#x2013;370 <pub-id pub-id-type="pmid">12555203</pub-id></citation>
      </ref>
      <ref id="CR176">
        <label>176.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mahajan</surname>
              <given-names>SD</given-names>
            </name>
          </person-group>
          <article-title>Morphine modulates chemokine gene regulation in normal human astrocytes</article-title>
          <source>Clin Immunol</source>
          <year>2005</year>
          <volume>115</volume>
          <fpage>323</fpage>
          <lpage>332</lpage>
        </citation>
        <citation citation-type="display-unstructured">Mahajan SD (2005) Morphine modulates chemokine gene regulation in normal human astrocytes. Clin Immunol 115:323&#x2013;332 <pub-id pub-id-type="pmid">15893700</pub-id></citation>
      </ref>
      <ref id="CR177">
        <label>177.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banisadr</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain</article-title>
          <source>J Neurochem</source>
          <year>2002</year>
          <volume>81</volume>
          <fpage>257</fpage>
          <lpage>269</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banisadr G (2002) Distribution, cellular localization and functional role of CCR2 chemokine receptors in adult rat brain. J Neurochem 81:257&#x2013;269 <pub-id pub-id-type="pmid">12064472</pub-id></citation>
      </ref>
      <ref id="CR178">
        <label>178.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jee</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>128</volume>
          <fpage>49</fpage>
          <lpage>57</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jee Y (2002) Upregulation of monocyte chemotactic protein-1 and CC chemokine receptor 2 in the central nervous system is closely associated with relapse of autoimmune encephalomyelitis in Lewis rats. J Neuroimmunol 128:49&#x2013;57 <pub-id pub-id-type="pmid">12098510</pub-id></citation>
      </ref>
      <ref id="CR179">
        <label>179.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2001</year>
          <volume>60</volume>
          <fpage>25</fpage>
          <lpage>32</lpage>
        </citation>
        <citation citation-type="display-unstructured">van der Meer P (2001) Expression pattern of CXCR3, CXCR4, and CCR3 chemokine receptors in the developing human brain. J Neuropathol Exp Neurol 60:25&#x2013;32 <pub-id pub-id-type="pmid">11202173</pub-id></citation>
      </ref>
      <ref id="CR180">
        <label>180.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Eugenin</surname>
              <given-names>EA</given-names>
            </name>
          </person-group>
          <article-title>HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS</article-title>
          <source>Glia</source>
          <year>2005</year>
          <volume>49</volume>
          <fpage>501</fpage>
          <lpage>510</lpage>
        </citation>
        <citation citation-type="display-unstructured">Eugenin EA (2005) HIV-1 tat protein induces a migratory phenotype in human fetal microglia by a CCL2 (MCP-1)-dependent mechanism: possible role in NeuroAIDS. Glia 49:501&#x2013;510 <pub-id pub-id-type="pmid">15578658</pub-id></citation>
      </ref>
      <ref id="CR181">
        <label>181.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galasso</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain</article-title>
          <source>Exp Neurol</source>
          <year>2000</year>
          <volume>165</volume>
          <fpage>295</fpage>
          <lpage>305</lpage>
        </citation>
        <citation citation-type="display-unstructured">Galasso JM (2000) Acute excitotoxic injury induces expression of monocyte chemoattractant protein-1 and its receptor, CCR2, in neonatal rat brain. Exp Neurol 165:295&#x2013;305 <pub-id pub-id-type="pmid">10993690</pub-id></citation>
      </ref>
      <ref id="CR182">
        <label>182.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Galasso</surname>
              <given-names>JM</given-names>
            </name>
          </person-group>
          <article-title>Experimental gliosarcoma induces chemokine receptor expression in rat brain</article-title>
          <source>Exp Neurol</source>
          <year>2000</year>
          <volume>161</volume>
          <fpage>85</fpage>
          <lpage>95</lpage>
        </citation>
        <citation citation-type="display-unstructured">Galasso JM (2000) Experimental gliosarcoma induces chemokine receptor expression in rat brain. Exp Neurol 161:85&#x2013;95 <pub-id pub-id-type="pmid">10683275</pub-id></citation>
      </ref>
      <ref id="CR183">
        <label>183.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Abbadie</surname>
              <given-names>C</given-names>
            </name>
          </person-group>
          <article-title>Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>2003</year>
          <volume>100</volume>
          <fpage>7947</fpage>
          <lpage>7952</lpage>
        </citation>
        <citation citation-type="display-unstructured">Abbadie C (2003) Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2. Proc Natl Acad Sci USA 100:7947&#x2013;7952 <pub-id pub-id-type="pmid">12808141</pub-id></citation>
      </ref>
      <ref id="CR184">
        <label>184.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Meer</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia</article-title>
          <source>Exp Mol Pathol</source>
          <year>2000</year>
          <volume>69</volume>
          <fpage>192</fpage>
          <lpage>201</lpage>
        </citation>
        <citation citation-type="display-unstructured">van der Meer P (2000) Immunohistochemical analysis of CCR2, CCR3, CCR5, and CXCR4 in the human brain: potential mechanisms for HIV dementia. Exp Mol Pathol 69:192&#x2013;201 <pub-id pub-id-type="pmid">11115360</pub-id></citation>
      </ref>
      <ref id="CR185">
        <label>185.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banisadr</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons</article-title>
          <source>J Comp Neurol</source>
          <year>2005</year>
          <volume>492</volume>
          <fpage>178</fpage>
          <lpage>192</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banisadr G (2005) Constitutive neuronal expression of CCR2 chemokine receptor and its colocalization with neurotransmitters in normal rat brain: functional effect of MCP-1/CCL2 on calcium mobilization in primary cultured neurons. J Comp Neurol 492:178&#x2013;192 <pub-id pub-id-type="pmid">16196033</pub-id></citation>
      </ref>
      <ref id="CR186">
        <label>186.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Simpson</surname>
              <given-names>JE</given-names>
            </name>
          </person-group>
          <article-title>Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions</article-title>
          <source>Neuropathol Appl Neurobiol</source>
          <year>2000</year>
          <volume>26</volume>
          <fpage>133</fpage>
          <lpage>142</lpage>
        </citation>
        <citation citation-type="display-unstructured">Simpson JE (2000) Expression of the interferon-gamma-inducible chemokines IP-10 and Mig and their receptor, CXCR3, in multiple sclerosis lesions. Neuropathol Appl Neurobiol 26:133&#x2013;142 <pub-id pub-id-type="pmid">10840276</pub-id></citation>
      </ref>
      <ref id="CR187">
        <label>187.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kremlev</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures</article-title>
          <source>J Neuroimmunol</source>
          <year>2005</year>
          <volume>162</volume>
          <fpage>71</fpage>
          <lpage>80</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kremlev SG (2005) Interleukin-10 inhibits endotoxin-induced pro-inflammatory cytokines in microglial cell cultures. J Neuroimmunol 162:71&#x2013;80 <pub-id pub-id-type="pmid">15833361</pub-id></citation>
      </ref>
      <ref id="CR188">
        <label>188.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kremlev</surname>
              <given-names>SG</given-names>
            </name>
          </person-group>
          <article-title>Differential expression of chemokines and chemokine receptors during microglial activation and inhibition</article-title>
          <source>J Neuroimmunol</source>
          <year>2004</year>
          <volume>149</volume>
          <fpage>1</fpage>
          <lpage>9</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kremlev SG (2004) Differential expression of chemokines and chemokine receptors during microglial activation and inhibition. J Neuroimmunol 149:1&#x2013;9 <pub-id pub-id-type="pmid">15020059</pub-id></citation>
      </ref>
      <ref id="CR189">
        <label>189.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Xia</surname>
              <given-names>MQ</given-names>
            </name>
          </person-group>
          <article-title>Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer&#x2019;s disease</article-title>
          <source>J Neuroimmunol</source>
          <year>2000</year>
          <volume>108</volume>
          <fpage>227</fpage>
          <lpage>235</lpage>
        </citation>
        <citation citation-type="display-unstructured">Xia MQ (2000) Expression of the chemokine receptor CXCR3 on neurons and the elevated expression of its ligand IP-10 in reactive astrocytes: in vitro ERK1/2 activation and role in Alzheimer&#x2019;s disease. J Neuroimmunol 108:227&#x2013;235 <pub-id pub-id-type="pmid">10900358</pub-id></citation>
      </ref>
      <ref id="CR190">
        <label>190.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lavi</surname>
              <given-names>E</given-names>
            </name>
          </person-group>
          <article-title>CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons</article-title>
          <source>Am J Pathol</source>
          <year>1997</year>
          <volume>151</volume>
          <fpage>1035</fpage>
          <lpage>1042</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lavi E (1997) CXCR-4 (Fusin), a co-receptor for the type 1 human immunodeficiency virus (HIV-1), is expressed in the human brain in a variety of cell types, including microglia and neurons. Am J Pathol 151:1035&#x2013;1042 <pub-id pub-id-type="pmid">9327737</pub-id></citation>
      </ref>
      <ref id="CR191">
        <label>191.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sanders</surname>
              <given-names>VJ</given-names>
            </name>
          </person-group>
          <article-title>Chemokines and receptors in HIV encephalitis</article-title>
          <source>AIDS</source>
          <year>1998</year>
          <volume>12</volume>
          <fpage>1021</fpage>
          <lpage>1026</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sanders VJ (1998) Chemokines and receptors in HIV encephalitis. AIDS 12:1021&#x2013;1026 <pub-id pub-id-type="pmid">9662198</pub-id></citation>
      </ref>
      <ref id="CR192">
        <label>192.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boutet</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4</article-title>
          <source>Glia</source>
          <year>2001</year>
          <volume>34</volume>
          <fpage>165</fpage>
          <lpage>177</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boutet A (2001) Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4. Glia 34:165&#x2013;177 <pub-id pub-id-type="pmid">11329179</pub-id></citation>
      </ref>
      <ref id="CR193">
        <label>193.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Guillemin</surname>
              <given-names>GJ</given-names>
            </name>
          </person-group>
          <article-title>Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes</article-title>
          <source>Glia</source>
          <year>2003</year>
          <volume>41</volume>
          <fpage>371</fpage>
          <lpage>381</lpage>
        </citation>
        <citation citation-type="display-unstructured">Guillemin GJ (2003) Quinolinic acid upregulates chemokine production and chemokine receptor expression in astrocytes. Glia 41:371&#x2013;381 <pub-id pub-id-type="pmid">12555204</pub-id></citation>
      </ref>
      <ref id="CR194">
        <label>194.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Okamoto</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases</article-title>
          <source>Biochem Biophys Res Commun</source>
          <year>2005</year>
          <volume>336</volume>
          <fpage>1214</fpage>
          <lpage>1220</lpage>
        </citation>
        <citation citation-type="display-unstructured">Okamoto M (2005) HIV-1-infected macrophages induce astrogliosis by SDF-1alpha and matrix metalloproteinases. Biochem Biophys Res Commun 336:1214&#x2013;1220 <pub-id pub-id-type="pmid">16169519</pub-id></citation>
      </ref>
      <ref id="CR195">
        <label>195.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sabri</surname>
              <given-names>F</given-names>
            </name>
          </person-group>
          <article-title>Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors</article-title>
          <source>Virology</source>
          <year>1999</year>
          <volume>264</volume>
          <fpage>370</fpage>
          <lpage>384</lpage>
        </citation>
        <citation citation-type="display-unstructured">Sabri F (1999) Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors. Virology 264:370&#x2013;384 <pub-id pub-id-type="pmid">10562499</pub-id></citation>
      </ref>
      <ref id="CR196">
        <label>196.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zheng</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia</article-title>
          <source>J Neuroimmunol</source>
          <year>1999</year>
          <volume>98</volume>
          <fpage>185</fpage>
          <lpage>200</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zheng J (1999) Intracellular CXCR4 signaling, neuronal apoptosis and neuropathogenic mechanisms of HIV-1-associated dementia. J Neuroimmunol 98:185&#x2013;200 <pub-id pub-id-type="pmid">10430052</pub-id></citation>
      </ref>
      <ref id="CR197">
        <label>197.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Banisadr</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons</article-title>
          <source>Eur J Neurosci</source>
          <year>2002</year>
          <volume>16</volume>
          <fpage>1661</fpage>
          <lpage>1671</lpage>
        </citation>
        <citation citation-type="display-unstructured">Banisadr G (2002) Neuroanatomical distribution of CXCR4 in adult rat brain and its localization in cholinergic and dopaminergic neurons. Eur J Neurosci 16:1661&#x2013;1671 <pub-id pub-id-type="pmid">12431218</pub-id></citation>
      </ref>
      <ref id="CR198">
        <label>198.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Jiang</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis</article-title>
          <source>J Neuroimmunol</source>
          <year>1998</year>
          <volume>86</volume>
          <fpage>1</fpage>
          <lpage>12</lpage>
        </citation>
        <citation citation-type="display-unstructured">Jiang Y (1998) Chemokine receptor expression in cultured glia and rat experimental allergic encephalomyelitis. J Neuroimmunol 86:1&#x2013;12 <pub-id pub-id-type="pmid">9655467</pub-id></citation>
      </ref>
      <ref id="CR199">
        <label>199.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Heesen</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-1alpha is a ligand for both CXC chemokine receptor-4 isoforms</article-title>
          <source>J Immunol</source>
          <year>1997</year>
          <volume>158</volume>
          <fpage>3561</fpage>
          <lpage>3564</lpage>
        </citation>
        <citation citation-type="display-unstructured">Heesen M (1997) Alternate splicing of mouse fusin/CXC chemokine receptor-4: stromal cell-derived factor-1alpha is a ligand for both CXC chemokine receptor-4 isoforms. J Immunol 158:3561&#x2013;3564 <pub-id pub-id-type="pmid">9103415</pub-id></citation>
      </ref>
      <ref id="CR200">
        <label>200.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Luo</surname>
              <given-names>Y</given-names>
            </name>
          </person-group>
          <article-title>RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes</article-title>
          <source>Glia</source>
          <year>2002</year>
          <volume>39</volume>
          <fpage>19</fpage>
          <lpage>30</lpage>
        </citation>
        <citation citation-type="display-unstructured">Luo Y (2002) RANTES stimulates inflammatory cascades and receptor modulation in murine astrocytes. Glia 39:19&#x2013;30 <pub-id pub-id-type="pmid">12112372</pub-id></citation>
      </ref>
      <ref id="CR201">
        <label>201.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>An</surname>
              <given-names>SF</given-names>
            </name>
          </person-group>
          <article-title>Expression of CCR-5/CXCR-4 in spinal cord of patients with AIDS</article-title>
          <source>Acta Neuropathol (Berl)</source>
          <year>2001</year>
          <volume>102</volume>
          <fpage>175</fpage>
          <lpage>180</lpage>
        </citation>
        <citation citation-type="display-unstructured">An SF (2001) Expression of CCR-5/CXCR-4 in spinal cord of patients with AIDS. Acta Neuropathol (Berl) 102:175&#x2013;180 <pub-id pub-id-type="pmid">11563633</pub-id></citation>
      </ref>
      <ref id="CR202">
        <label>202.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Vallat</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS</article-title>
          <source>Am J Pathol</source>
          <year>1998</year>
          <volume>152</volume>
          <fpage>167</fpage>
          <lpage>178</lpage>
        </citation>
        <citation citation-type="display-unstructured">Vallat AV (1998) Localization of HIV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS. Am J Pathol 152:167&#x2013;178 <pub-id pub-id-type="pmid">9422534</pub-id></citation>
      </ref>
      <ref id="CR203">
        <label>203.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Albright</surname>
              <given-names>AV</given-names>
            </name>
          </person-group>
          <article-title>Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates</article-title>
          <source>J Virol</source>
          <year>1999</year>
          <volume>73</volume>
          <fpage>205</fpage>
          <lpage>213</lpage>
        </citation>
        <citation citation-type="display-unstructured">Albright AV (1999) Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates. J Virol 73:205&#x2013;213 <pub-id pub-id-type="pmid">9847323</pub-id></citation>
      </ref>
      <ref id="CR204">
        <label>204.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boutet</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons</article-title>
          <source>Neurosci Lett</source>
          <year>2001</year>
          <volume>311</volume>
          <fpage>105</fpage>
          <lpage>108</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boutet A (2001) Cellular expression of functional chemokine receptor CCR5 and CXCR4 in human embryonic neurons. Neurosci Lett 311:105&#x2013;108 <pub-id pub-id-type="pmid">11567789</pub-id></citation>
      </ref>
      <ref id="CR205">
        <label>205.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Lecointe</surname>
              <given-names>D</given-names>
            </name>
          </person-group>
          <article-title>Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages</article-title>
          <source>Microbes Infect</source>
          <year>2002</year>
          <volume>4</volume>
          <fpage>1401</fpage>
          <lpage>1408</lpage>
        </citation>
        <citation citation-type="display-unstructured">Lecointe D (2002) Human cytomegalovirus infection reduces surface CCR5 expression in human microglial cells, astrocytes and monocyte-derived macrophages. Microbes Infect 4:1401&#x2013;1408 <pub-id pub-id-type="pmid">12475630</pub-id></citation>
      </ref>
      <ref id="CR206">
        <label>206.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kanmogne</surname>
              <given-names>GD</given-names>
            </name>
          </person-group>
          <article-title>Infection of baboon microglia with SIV&#x2013;HIV recombinant viruses: role of CD4 and chemokine receptors</article-title>
          <source>AIDS Res Hum Retroviruses</source>
          <year>2002</year>
          <volume>18</volume>
          <fpage>557</fpage>
          <lpage>565</lpage>
        </citation>
        <citation citation-type="display-unstructured">Kanmogne GD (2002) Infection of baboon microglia with SIV&#x2013;HIV recombinant viruses: role of CD4 and chemokine receptors. AIDS Res Hum Retroviruses 18:557&#x2013;565 <pub-id pub-id-type="pmid">12036485</pub-id></citation>
      </ref>
      <ref id="CR207">
        <label>207.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages</article-title>
          <source>Immunology</source>
          <year>2005</year>
          <volume>114</volume>
          <fpage>565</fpage>
          <lpage>574</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen S (2005) Transforming growth factor-beta1 increases CXCR4 expression, stromal-derived factor-1alpha-stimulated signalling and human immunodeficiency virus-1 entry in human monocyte-derived macrophages. Immunology 114:565&#x2013;574 <pub-id pub-id-type="pmid">15804293</pub-id></citation>
      </ref>
      <ref id="CR208">
        <label>208.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Petito</surname>
              <given-names>CK</given-names>
            </name>
          </person-group>
          <article-title>Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS</article-title>
          <source>J Neuropathol Exp Neurol</source>
          <year>2001</year>
          <volume>60</volume>
          <fpage>377</fpage>
          <lpage>385</lpage>
        </citation>
        <citation citation-type="display-unstructured">Petito CK (2001) Hippocampal injury and alterations in neuronal chemokine co-receptor expression in patients with AIDS. J Neuropathol Exp Neurol 60:377&#x2013;385 <pub-id pub-id-type="pmid">11305873</pub-id></citation>
      </ref>
      <ref id="CR209">
        <label>209.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Hesselgesser</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons</article-title>
          <source>Curr Biol</source>
          <year>1997</year>
          <volume>7</volume>
          <fpage>112</fpage>
          <lpage>121</lpage>
        </citation>
        <citation citation-type="display-unstructured">Hesselgesser J (1997) CD4-independent association between HIV-1 gp120 and CXCR4: functional chemokine receptors are expressed in human neurons. Curr Biol 7:112&#x2013;121 <pub-id pub-id-type="pmid">9024623</pub-id></citation>
      </ref>
      <ref id="CR210">
        <label>210.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Westmoreland</surname>
              <given-names>SV</given-names>
            </name>
          </person-group>
          <article-title>Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>122</volume>
          <fpage>146</fpage>
          <lpage>158</lpage>
        </citation>
        <citation citation-type="display-unstructured">Westmoreland SV (2002) Developmental expression patterns of CCR5 and CXCR4 in the rhesus macaque brain. J Neuroimmunol 122:146&#x2013;158 <pub-id pub-id-type="pmid">11777554</pub-id></citation>
      </ref>
      <ref id="CR211">
        <label>211.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zhang</surname>
              <given-names>L</given-names>
            </name>
          </person-group>
          <article-title>In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5</article-title>
          <source>J Virol</source>
          <year>1998</year>
          <volume>72</volume>
          <fpage>5035</fpage>
          <lpage>5045</lpage>
        </citation>
        <citation citation-type="display-unstructured">Zhang L (1998) In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5. J Virol 72:5035&#x2013;5045 <pub-id pub-id-type="pmid">9573273</pub-id></citation>
      </ref>
      <ref id="CR212">
        <label>212.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Chen</surname>
              <given-names>S</given-names>
            </name>
          </person-group>
          <article-title>TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia</article-title>
          <source>J Neuroimmunol</source>
          <year>2002</year>
          <volume>133</volume>
          <fpage>46</fpage>
          <lpage>55</lpage>
        </citation>
        <citation citation-type="display-unstructured">Chen S (2002) TGF-beta1 upregulates CX3CR1 expression and inhibits fractalkine-stimulated signaling in rat microglia. J Neuroimmunol 133:46&#x2013;55 <pub-id pub-id-type="pmid">12446007</pub-id></citation>
      </ref>
      <ref id="CR213">
        <label>213.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Tarozzo</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia&#x2013;reperfusion brain injury in the rat</article-title>
          <source>Eur J Neurosci</source>
          <year>2002</year>
          <volume>15</volume>
          <fpage>1663</fpage>
          <lpage>1668</lpage>
        </citation>
        <citation citation-type="display-unstructured">Tarozzo G (2002) Expression of fractalkine and its receptor, CX3CR1, in response to ischaemia&#x2013;reperfusion brain injury in the rat. Eur J Neurosci 15:1663&#x2013;1668 <pub-id pub-id-type="pmid">12059974</pub-id></citation>
      </ref>
      <ref id="CR214">
        <label>214.</label>
        <citation citation-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Boddeke</surname>
              <given-names>EW</given-names>
            </name>
          </person-group>
          <article-title>Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia</article-title>
          <source>Eur J Pharmacol</source>
          <year>1999</year>
          <volume>374</volume>
          <fpage>309</fpage>
          <lpage>313</lpage>
        </citation>
        <citation citation-type="display-unstructured">Boddeke EW (1999) Functional expression of the fractalkine (CX3C) receptor and its regulation by lipopolysaccharide in rat microglia. Eur J Pharmacol 374:309&#x2013;313 <pub-id pub-id-type="pmid">10422773</pub-id></citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>